10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

OR

☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                  

Commission File No. 001-40900

ROSE HILL ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

Cayman Islands	N/A
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

981 Davis Dr NW, Atlanta, Georgia 30327

(Address of Principal Executive Offices, including zip code)

(607) 279 2371

(Registrant’s telephone number, including area code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant	ROSEU	Nasdaq Global Market
Class A ordinary shares, par value $0.0001 per share	ROSE	Nasdaq Global Market
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share	ROSEW	Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act):    Yes  ☒    No  ☐

As of August 11, 2023, there were 4,256,893 Class A ordinary shares, par value $0.0001 per share, and 1,031,250 Class B ordinary shares, $0.0001 par value per share, issued and outstanding.

ROSE HILL ACQUISITION CORPORATION

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
PART 1 — FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022	1
	Condensed Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited)	2
	Condensed Statements of Changes in Redeemable Ordinary Shares and Shareholders’ Deficit for the three and six months ended June 30, 2023 and 2022 (Unaudited)	3
	Condensed Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)	4
	Notes to Condensed Financial Statements (Unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21
Item 4.	Control and Procedures	22
PART II — OTHER INFORMATION
Item 6.	Exhibits	23
Signatures		24

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

ROSE HILL ACQUISITION CORPORATION

CONDENSED BALANCE SHEETS

	June 30, 2023 (Unaudited)			December 31, 2022
ASSETS
CURRENT ASSETS
Cash	$	3,577		$	96,119
Prepaid expenses		—			104,905
Due from affiliates		25,000			25,000
Total current assets		28,577			226,024
NON – CURRENT ASSETS
Investments held in Trust Account		2,917,376			148,742,661
Total Non – Current Assets		2,917,376			148,742,661
TOTAL ASSETS	$	2,945,953		$	148,968,685
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	1,196,239		$	223,997
Total current liabilities		1,196,239			223,997
LONG TERM LIABILITIES
Derivative warrant liabilities		332,188			1,328,750
Deferred underwriting fee payable		1,500,000			7,187,500
Total long-term liabilities		1,832,188			8,516,250
Total liabilities		3,028,427			8,740,247
COMMITMENTS AND CONTINGENCIES (NOTE 4)
Class A ordinary shares subject to possible redemption, $0.0001 par value, 256,893 and 14,375,000 shares at redemption value at June 30, 2023 and December 31, 2022, respectively		2,917,376			148,742,661
SHAREHOLDERS’ DEFICIT
Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2023 and December 31, 2022 respectively		—			—
Class A ordinary shares; $0.0001 par value; 200,000,000 shares authorized; 4,000,000 and 0 shares issued and outstanding (excluding 256,893 and 14,375,000 shares subject to possible redemption) at June 30, 2023 and December 31, 2022		400			—
Class B ordinary shares; $0.0001 par value; 20,000,000 shares authorized; 1,031,250 and 5,031,250 shares issued and outstanding at June 30, 2023 and December 31, 2022 respectively		103			503
Additional paid-in capital		—			—
Accumulated deficit		(3,000,353	)		(8,514,726	)
Total shareholders’ deficit		(2,999,850	)		(8,514,223	)
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT	$	2,945,953		$	148,968,685

The accompanying notes are an integral part of these unaudited condensed financial statements

1

ROSE HILL ACQUISITION CORPORATION

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022
OPERATING EXPENSES
General and administrative expenses	$	909,264		$	325,978		$	1,170,972		$	611,146
Loss from operations		(909,264	)		(325,978	)		(1,170,972	)		(611,146	)
Other income:
Earnings on investments held in Trust Account and other interest		34,775			198,121			435,595			212,901
Recovery of offering costs allocated to warrants		—			—			270,725			—
Change in fair value of warrants		465,062			256,204			996,562			3,207,910
Total other income		499,837			454,325			1,702,882			3,420,811
Net (loss) income	$	(409,427	)	$	128,347		$	531,910		$	2,809,665
Weighted average shares outstanding of Class A ordinary shares subject to redemption		256,894			14,375,000			1,036,900			14,375,000
Basic and diluted net income per share, Class A ordinary shares subject to redemption	$	0.05		$	0.01		$	0.43		$	0.15
Weighted average shares outstanding of Class A and Class B ordinary shares not subject to redemption		5,031,250			5,031,250			5,031,250			5,031,250
Basic and diluted net (loss) income  per share, Class A and Class B ordinary shares not subject to redemption	$	(0.08	)	$	(0.00	)	$	0.02		$	0.13

The accompanying notes are an integral part of these unaudited condensed financial statements

2

ROSE HILL ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CHANGES IN REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

	Class A ordinary shares subject to possible redemption						Class A ordinary shares not subject to possible redemption				Class B ordinary shares						Additional paid-in capital		Accumulated deficit			Total Shareholders’ Deficit
	Shares			Amount			Shares		Amount		Shares			Amount
Balance, January 1, 2023		14,375,000		$	148,742,661		$	—	$	—	$	5,031,250		$	503		$	—	$	(8,514,726	)	$	(8,514,223	)
Redemptions		(14,118,106	)		(146,259,586	)		—		—		—			—			—		—			—
Recovery of Deferred Underwriter Commissions		—			—			—		—		—			—			—		5,416,775			5,416,775
Remeasurement of redeemable Class A ordinary shares to redemption value		—			399,927			—		—		—			—			—		(399,927	)		(399,927	)
Reclassification of Class B shares to Class A shares		—			—			4,000,000		400		(4,000,000	)		(400	)		—		—			—
Net income		—			—			—		—		—			—			—		941,337			941,337
Balance, March 31, 2023		256,894			2,883,002			4,000,000		400		1,031,250			103			—		(2,556,541	)		(2,556,038	)
Remeasurement of redeemable Class A ordinary shares to redemption value		—			34,385			—		—		—			—			—		(34,385	)		(34,385	)
Redemptions		(1	)		(11	)
Net loss		—			—			—		—		—			—			—		(409,427	)		(409,427	)
Balance, June 30, 2023		256,893		$	2,917,376		$	4,000,000	$	400	$	1,031,250		$	103		$	—	$	(3,000,353	)	$	(2,999,850	)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

	Class A ordinary shares subject to possible redemption				Class A ordinary shares not subject to possible redemption				Class B ordinary shares				Additional paid-in capital		Accumulated deficit			Total Shareholders’ Deficit
	Shares		Amount		Shares		Amount		Shares		Amount
Balance, January 1, 2022		14,375,000	$	146,625,000	$	—	$	—	$	5,031,250	$	503	$	—	$	(12,607,205	)	$	(12,606,702	)
Remeasurement of redeemable Class A ordinary shares to redemption value		—		17,509		—		—		—		—		—		(17,509	)		(17,509	)
Net income		—		—		—		—		—		—		—		2,681,318			2,681,318
Balance, March 31, 2022		14,375,000		146,642,509		—		—		5,031,250		503		—		(9,943,396	)		(9,942,893	)
Remeasurement of redeemable Class A ordinary shares to redemption value		—		197,982		—		—		—		—		—		(197,982	)		(197,982	)
Net income		—		—		—		—		—		—		—		128,347			128,347
Balance, June 30, 2022		14,375,000	$	146,840,491	$	—	$	—	$	5,031,250	$	503	$	—	$	(10,013,031	)	$	(10,012,528	)

The accompanying notes are an integral part of these unaudited condensed financial statements

3

ROSE HILL ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

	For the Six Months Ended June 30,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	531,910		$	2,809,665
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Earnings on investments held in Trust Account		—			(212,762	)
Recovery of offering costs allocated to warrants		(270,725	)		—
Change in fair value of warrants		(996,562	)		(3,207,910	)
Changes in operating assets and liabilities:
Prepaid expenses		104,905			153,786
Accounts payable and accrued expenses		972,242			136,841
Net cash provided by (used in) operating activities		341,770			(320,380	)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash withdrawn from Trust Account in connection with redemption		146,259,597			—
Reinvestment of dividend income on Trust Account		(434,312	)		—
Net cash provided by investing activities		145,825,285			—
CASH FLOWS FROM FINANCING ACTIVITIES
Redemption of Class A common stock subject to possible redemption		(146,259,597	)		—
Net cash used in financing activities		(146,259,597	)		—
NET CHANGE IN CASH	$	(92,542	)	$	(320,380	)
CASH, BEGINNING OF PERIOD		96,119			658,747
CASH, END OF PERIOD	$	3,577		$	338,367
Non-cash investing and financing activities:
Reclassification of Class B shares to Class A shares	$	400		$	—
Impact of the recovery of deferred commission by the underwriters	$	5,416,775		$	—
Remeasurement of redeemable Class A ordinary shares to redemption value	$	434,312		$	215,491

The accompanying notes are an integral part of these unaudited condensed financial statements

4

ROSE HILL ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1 — Description of Organization and Business Operations

Rose Hill Acquisition Corporation (the “Company”) was incorporated in the Cayman Islands on March 29, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (an “Initial Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had not commenced any operations. Activity through June 30, 2023, relates to the Company’s formation and initial public offering (“IPO”), which is described below and, since the IPO, the search for a prospective Initial Business Combination. The Company will not generate any operating revenues until after the completion of its Initial Business Combination, at the earliest. The Company generates non-operating income in the form of earnings on investments from the proceeds derived from the IPO.

The registration statement for the Company’s IPO was declared effective on October 13, 2021. On October 18, 2021, the Company consummated the IPO of 12,500,000 units (“Units”) with respect to the Class A ordinary shares included in the units being offered (the “Public Shares”) at $10.00 per unit generating gross proceeds of $125,000,000.

The Company had until January 18, 2023, 15 months from the closing of the IPO to complete an Initial Business Combination. On January 12, 2023, the shareholders approved a proposal, as a special resolution, to amend the Company’s amended and restated memorandum and articles of association (“Articles”) to extend the date by which the Company must complete its Initial Business Combination from January 18, 2023, to July 18, 2023 (“Extension Proposal”). Additionally, the shareholders approved a proposal, as a special resolution, to amend the Articles to acknowledge and clarify that pursuant to the Articles, approval of the Company’s Initial Business Combination requires an ordinary resolution (“Clarification Proposal”). In connection with the vote to approve the Extension Proposal and Clarification Proposal, the holders of 14,118,106 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of approximately $146,000,000 million. Following such redemption, the amount of funds remaining in the Company’s trust account was approximately $2.8 million.

On June 29, 2023, the Company held an extraordinary general meeting of shareholders (the “Meeting”). The Company’s shareholders approved the proposal, as a special resolution, to amend the Articles to extend the date by which the Company must complete its Initial Business Combination from July 18, 2023, to January 18, 2024. In connection with the vote to approve the Extension Proposal, the holder of one Class A ordinary share of the Company exercised their right to redeem their share for a total redemption amount of $11.

Following the closing of the IPO, $146,625,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Warrants, including the amounts generated from the exercise of the underwriters’ over-allotment option, was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of an Initial Business Combination and (ii) the distribution of the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating an Initial Business Combination. There is no assurance that the Company will be able to complete an Initial Business Combination successfully. The Company must complete one or more Initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account at the time of the agreement to enter into the Initial Business Combination. However, the Company will only complete an Initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect an Initial Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an Initial Business Combination either (i) in connection with a shareholder meeting called to approve the Initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of an Initial Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights with respect to the Company’s warrants.

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Initial Business Combination and in connection with certain amendments to the Articles. In accordance with the rules of the SEC and its guidance on redeemable equity instruments, which has been codified in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A ordinary shares is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001 in connection with approval of an Initial Business Combination, the Public Shares are redeemable and are classified as such on the balance sheet until such date that a redemption event takes place.

5

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Initial Business Combination. If the Company seeks shareholder approval of the Initial Business Combination, the Company will proceed with an Initial Business Combination if a majority of the shares voted are voted in favor of the Initial Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Articles conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing an Initial Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with an Initial Business Combination, Rose Hill Sponsor LLC (the “Sponsor”) has agreed to vote its Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of approving an Initial Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, the Articles provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the IPO, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Articles that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete an Initial Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete an Initial Business Combination during the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company’s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

On January 24, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with certain requirements of the Nasdaq Listing Rules set forth in (i) 5450(b)(2)(B), requiring a minimum of 1,100,000 Publicly Held Shares, (ii) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market Value of Listed Securities, (iii) Listing Rule 5450(b)(2)(C), requiring a minimum of $15 million in Market Value of Publicly Held Shares and (iv) Listing Rule 5450(a)(2), requiring a minimum of 400 Total Holders (collectively, the “Nasdaq Listing Rules”).

On March 24, 2023, Nasdaq granted the Company an extension until July 24, 2023, by which time the Company must file with the SEC and Nasdaq a public document showing compliance with the Nasdaq Listing Rules. If the Company is unable to regain compliance with the Nasdaq Listing Rules by July 24, 2023, it may be subject to delisting procedures as set forth in the Nasdaq continued listing rules.

On July 26, 2023, the Company received a delisting determination letter (the “Determination Letter”) from the Staff notifying the Company that (i) it had not regained compliance with Nasdaq Listing Rule 5550(a)(4) requiring a minimum of 500,000 publicly held shares and (ii) the Company’s Class A ordinary shares, warrants and units would be subject to delisting from The Nasdaq Capital Market. The Determination Letter further noted that, unless the Company requests an appeal of the Staff’s determination with the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s Class A ordinary shares, warrants and units on The Nasdaq Capital Market would be suspended at the opening of business on August 4, 2023, and a Form 25-NSE would be filed with the SEC removing the Company’s securities from listing and registration on The Nasdaq Capital Market.

With respect to the Determination Letter, on August 1, 2023, the Company requested a hearing before the Panel to appeal the Staff’s determination. The hearing before the Panel is expected to occur on October 5, 2023. The hearing request will stay the suspension and delisting of the Company’s securities pending a decision by the Panel. The Panel may, in its discretion, grant the Company an additional compliance period to regain compliance and maintain its Nasdaq listing; however, there can be no assurance that the Panel will grant such additional time.

Conversion of Class B Ordinary Shares held by the Sponsor

On February 28, 2023, the Sponsor converted 4,000,000 of its Class B ordinary shares to Class A ordinary shares on a 1:1 basis as part of the Company’s plan to regain compliance with the Nasdaq Listing Rules. The Sponsor’s converted Class A ordinary shares are not subject to redemptions and have no rights to funds in the Trust Account.

Founder Shares

Founder Shares refers to the 5,031,250 Class B ordinary shares acquired by the Sponsor prior to the IPO and following the conversion of the Sponsor’s Class B ordinary shares on February 28, 2023, consists of 1,031,250 Class B ordinary shares and 4,000,000 non-redeemable Class A ordinary shares held by the Sponsor.

The 1,031,250 Class B ordinary shares held by the Sponsor will automatically convert into Class A ordinary shares at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment, at any time.

6

The Initial Shareholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property.

The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares (including the Class A ordinary shares held by the Sponsor) if the Company fails to complete an Initial Business Combination during the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete an Initial Business Combination during the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 4) held in the Trust Account in the event the Company does not complete an Initial Business Combination during the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Going Concern and Liquidity

As of June 30, 2023, the Company had $3,577 in its operating bank accounts, $2,917,376 in securities held in the Trust Account to be used for an Initial Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $1,167,662.

Until the consummation of an Initial Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Initial Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing.

If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed financial statements. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Business Combination with Prize

Business Combination Agreement

On October 20, 2022, the Company entered into a Business Combination Agreement with Inversiones e Inmobilaria GHC Ltda, a limited liability company organized under the laws of Chile (“Prize”) and, for certain limited purposes, Alejandro García Huidobro Empresario Individual (“AGH”) (as amended on July 17, 2023 and as it may be further amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), pursuant to which, and subject to the terms and conditions set forth therein, prior to the consummation of the Business Combination (as defined below), (i) Prize caused to be incorporated under the laws of the Cayman Islands, (a) an exempted company with limited liability to serve as “PubCo” for all purposes under the Business Combination Agreement and (b) an exempted company with limited liability to serve as “Merger Sub” for all purposes under the Business Combination Agreement, (ii) Prize and AGH caused to be incorporated under the laws of Chile, a simplified stock corporation that will serve as “HoldCo” for all purposes under the Business Combination Agreement, in each case, as a direct wholly owned subsidiary of Prize and (iii) Prize and AGH will consummate a pre-closing restructuring pursuant to which, among other things, all subsidiaries of Prize will become direct or indirect subsidiaries of HoldCo, HoldCo will become a wholly owned subsidiary of Merger Sub, and Merger Sub will become a wholly owned subsidiary of Prize (collectively, the “Pre-Closing Restructuring”).

7

Following the Pre-Closing Restructuring, at the closing of the Business Combination, (i) the Company will be merged with and into PubCo with PubCo continuing as the surviving entity (the “First Merger”) and (ii) subsequent to the First Merger, Merger Sub will be merged with and into PubCo with PubCo continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers”) (such transactions and those otherwise contemplated by the Business Combination Agreement, collectively, the “Business Combination”).

The terms of the Business Combination Agreement, which contains customary representations and warranties, covenants, closing conditions and other terms relating to the Business Combination, are summarized below. Capitalized terms used in this Quarterly Report for the quarter ended June 30, 2023 (“Quarterly Report”) but not otherwise defined herein have the meanings given to them in the Business Combination Agreement, which is included as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2022.

Consideration

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the First Merger, (i) each Rose Hill ordinary share that is issued and outstanding immediately prior to the First Merger will be converted into one validly issued, fully paid and non-assessable PubCo ordinary share, and (ii) all outstanding warrants to purchase ordinary shares of Rose Hill will be converted into warrants to purchase the same number of PubCo ordinary shares and all rights with respect to Rose Hill ordinary shares under such Rose Hill warrants will be converted into rights with respect to the applicable PubCo ordinary shares.

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the Second Merger, each Merger Sub ordinary share that is issued and outstanding immediately prior to the Second Merger will be converted into a number of PubCo ordinary shares equal to the quotient of (i) the Equity Value, divided by (ii) the number of Merger Sub ordinary shares that are issued and outstanding immediately prior to the Second Merger, divided by (iii) $10.00. The “Equity Value” under the Business Combination Agreement is an amount equal to (i) $328,000,000, minus (ii) the lesser of (a) the aggregate amount of transaction expenses (the “Specified Transaction Expenses”) of Prize and the Company (other than those expenses incurred in respect of obtaining an equity line of credit or similar financing arrangement to be in place and available to PubCo as of the closing of the Business Combination (“Closing”)) and (b) $10,000,000.

In the event that the Specified Transaction Expenses exceed $10,000,000, then the number of PubCo ordinary shares otherwise issuable to Rose Hill Sponsor LLC (the “Sponsor”) under the Business Combination Agreement will be decreased by a number of shares equal to the amount of such excess divided by $10.00.

On July 17, 2023, Rose Hill, Prize and AGH, entered into Amendment No. 1 to Business Combination Agreement (the “Amendment”), pursuant to which the parties amended the Business Combination Agreement to (i) clarify the amount of shares to be issued by Merger Sub to Prize in connection with the Pre-Closing Restructuring (ii) permit Prize and AGH to solicit, initiate, enter into or continue discussions, negotiations or transactions with, or encourage or respond to any inquiries or proposals by, or provide any information to, any Person, concerning any merger, consolidation, sale of ownership interests and/or substantial portion of the assets, recapitalization or similar transaction of, by or involving Prize, HoldCo, PubCo or Merger Sub and terminate the BCA to enter into a definitive agreement with respect to any such transaction, in each case, until such time as Rose Hill, Prize and applicable investors agree in writing to the key economic terms of subscription agreements with respect to PIPE investments that, if consummated, would result in the receipt of proceeds of at least $50.0 million in the aggregate to PubCo in connection with the consummation of the Closing, and (iii) extend the date by which either Rose Hill, Prize or AGH can terminate the Business Combination Agreement, if the transactions contemplated thereby have not been consummated by such date, from July 18, 2023 to October 18, 2023.

Additionally, Prize has agreed to pay certain operating costs of the Company. For the three and six months ended June 30, 2023, Prize has reimbursed the Company $35,000 and $105,000, respectively, in operating costs. The Company accounts for these funds as contra-expenses in the statements of operations.

Earn-Out Shares

If, at any time following the Closing, the daily volume-weighted average price (“VWAP”) of PubCo ordinary shares is greater than or equal to (a) $18.00, (b) $22.00, (c) $26.00, or (d) $30.00 in each case, over any thirty (30) days on which the PubCo ordinary shares are tradeable on Nasdaq (“Trading Days”) within any consecutive forty-five (45) Trading Day period then PubCo will issue 2,948,800 PubCo ordinary shares to Prize (“Earn-Out Shares”) after the occurrence of each such consecutive forty-five (45) Trading Day period. For the avoidance of doubt, Prize may be entitled to receive a maximum of 11,795,200 Earn-Out Shares in the aggregate in respect of the occurrence of all four Earn-Out Events.

Registration Rights and Lock-up Agreement

In connection with the Closing of the Business Combination Agreement, PubCo, the Sponsor, Prize and certain other parties thereto will enter into a registration rights and lock-up agreement (the “Registration Rights and Lock-Up Agreement”), which, among other things, (i) effective as of the Closing, terminates and replaces the current registration rights agreement, dated as of October 13, 2021, by and among Rose Hill, the Sponsor and the other parties thereto, (ii) provides that PubCo will be obligated to file a registration statement to register the resale of certain PubCo ordinary shares held by Sponsor, Prize and certain other parties thereto, at the consummation of the Business Combination, (iii) provides certain parties thereto including Prize, certain demand and piggyback registration rights, and (iv) provides for certain restrictions on transfer relating to PubCo ordinary shares and warrants to purchase PubCo ordinary shares held by Sponsor, Prize and certain parties thereto.

Company Support Agreement

In connection with the execution of the Business Combination Agreement, Rose Hill, Prize and AGH have entered into a company support agreement (the “Company Support Agreement”) pursuant to which, among other things, AGH has agreed to (a) vote his Merger Sub ordinary shares in favor of the approval and adoption of the Business Combination Agreement and the Business Combination and (b) certain transfer restrictions with respect to his Merger Sub ordinary shares and shares of Prize.

Sponsor Support Agreement

In connection with the execution of the Business Combination Agreement, the Sponsor entered into a sponsor support agreement (the “Sponsor Support Agreement”) pursuant to which the Sponsor has agreed, among other things, to (i) certain restrictions on transfer relating to its ordinary shares of Rose Hill prior to the Closing as set forth therein, (ii) not redeem any of its shares of Rose Hill in connection with the vote to approve the Business Combination or any proposal to extend the date by which Rose Hill must complete an Initial Business Combination, (iii) vote in favor of the Mergers and the other transactions and against any alternative transaction, (iv) waive certain anti-dilution provisions contained in Rose Hill’s Articles in connection with the Mergers and (v) subject a certain number of its Class B ordinary shares of Rose Hill to vesting.

Sponsor Support Agreement Amendment

On July 31, 2023, Rose Hill, the Sponsor, Prize and Prize SuperFoods (“PubCo”), entered into Amendment No. 1 to the Sponsor Support Agreement (the “Amendment”), pursuant to which the parties amended the Sponsor Support Agreement to reflect the parties mutual agreement at the time the Business Combination Agreement, dated as of October 19, 2022, by and among Rose Hill, GHC and, for certain limited purposes, Alejandro García-Huidobro Empresario, an individual (the “Business Combination Agreement”), was executed that the Sponsor will forfeit 3,631,250 Rose Hill ordinary shares immediately prior to the transactions contemplated by the Business Combination Agreement such that the Sponsor will own 1,400,000 Rose Hill ordinary shares immediately following the forfeiture, 700,000 of which are subject to vesting conditions, as described in the Sponsor Support Agreement.

8

Standby Equity Purchase Agreement

In connection with the execution of the Business Combination Agreement and for purposes of obtaining equity financing on behalf of PubCo at Closing, Prize entered into a standby equity purchase agreement with a financial investor and affiliate of Yorkville Advisors (the “Investor”), pursuant to which, among other things, at the Closing, PubCo will have the right (but not the obligation) to sell to the Investor, and the Investor will purchase from PubCo, up to $150,000,000 of PubCo ordinary shares at a purchase price of 97% of the Market Price (as defined therein) of the PubCo ordinary shares, subject to the terms and conditions set forth therein.

Risks and Uncertainties

The credit and financial markets have experienced extreme volatility and disruptions due in part to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the statement of financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, for the year ended December 31, 2022, as filed with the SEC on March 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of June 30, 2023, is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2023, or for any future interim periods.

Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

9

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $3,577 and $96,119 of cash and no cash equivalents as of June 30, 2023 and December 31, 2022, respectively.

Investments Held in Trust Account

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held U.S. Money Market Funds primarily invested in U.S. Treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At June 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

FASB ASC 740, “Income Taxes”, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023, or December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

10

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. At June 30, 2023 and December 31, 2022, 256,893 and 14,375,000 shares of Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. At June 30, 2023 and December 31, 2022, 4,000,000 and 0 shares of Class A ordinary shares not subject to possible redemption is presented as equity as a component of shareholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Net Income per ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares subject to possible redemption or Public Shares and the Founder Shares which include the Class B ordinary shares and the Class A ordinary shares held by the Sponsor, not subject to possible redemption. Earnings and losses are shared pro rata between the two classes of shares. Public Warrants and Private Placement Warrants to purchase 13,287,500 ordinary shares at $11.50 per share were issued on October 18, 2021. At June 30, 2023 and 2022, no Public Warrants or Private Placement Warrants have been exercised. The 13,287,500 potential shares of Class A ordinary shares for outstanding Public Warrants and Private Placement Warrants to purchase the Company’s shares were excluded from diluted earnings per share for the three and six months ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary shares is the same as basic net income per ordinary shares for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of share.

For the three months ended June 30, 2023:

Net loss	$	(409,427	)
Less: Accretion of temporary equity to redemption value		(34,385	)
Net loss excluding accretion of temporary equity to redemption	$	(443,812	)

11

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Ownership percentage		5	%		95	%
Total loss allocated	$	(19,890	)	$	(389,537	)	$	(409,427	)
Less: Accretion allocated based on ownership percentage		(1,670	)		(32,715	)		(34,385	)
Plus: Accretion applicable to Class A redeemable shares		34,385			—			34,385
Total income (loss) by class	$	12,825		$	(422,252	)	$	(409,427	)
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Income (loss) per share	$	0.05		$	(0.08	)

For the three months ended June 30, 2022:

Net income	$	128,347
Less: Accretion of temporary equity to redemption value		(198,121	)
Net income excluding accretion of temporary equity to redemption	$	(69,774	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	95,072		$	33,275		$	128,347
Less: Accretion allocated based on ownership percentage		(146,756	)		(51,365	)		(198,121	)
Plus: Accretion applicable to Class A redeemable shares		198,121			—			198,121
Total income by class	$	146,437		$	(18,090	)	$	128,347
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.01		$	—

For the six months ended June 30, 2023:

Net income	$	531,910
Less: Accretion of temporary equity to redemption value		(434,312	)
Net income excluding accretion of temporary equity to redemption	$	97,598

	Class A shares subject to redemption			Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Ownership percentage		17	%		83	%
Total income allocated	$	90,891		$	441,019		$	531,910
Less: Accretion allocated based on ownership percentage		(74,213	)		(360,099	)		(434,312	)
Plus: Accretion applicable to Class A redeemable shares		434,312			—			434,312
Total income by class	$	450,990		$	80,920		$	531,910
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Income per share	$	0.43		$	0.02

For the six months ended June 30, 2022:

Net income	$	2,809,665
Less: Accretion of temporary equity to redemption value		(212,901	)
Net income excluding accretion of temporary equity to redemption	$	2,596,764

12

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	2,081,233		$	728,432		$	2,809,665
Less: Accretion allocated based on ownership percentage		(157,704	)		(55,197	)		(212,901	)
Plus: Accretion applicable to Class A redeemable shares		212,901			—			212,901
Total income by class	$	2,136,430		$	673,235		$	2,809,665
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.15		$	0.13

Accounting for Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own ordinary shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants issued pursuant to the warrant agreement qualify for liability accounting treatment.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Note 3 — Related Party Transactions

Working Capital Loans

In order to finance transaction costs in connection with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an Initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an Initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of an Initial Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Initial Business Combination entity at a price of $1.25 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding.

13

Support Services

The Company pays for services related to office space a fee of up to $10,000 per month following the consummation of the IPO until the earlier of the consummation of the Initial Business Combination or liquidation. In addition, the Company may make payments of up to $13,000 per month to members of the management team for services rendered to the Company commencing on the date that the Company's securities are first listed on Nasdaq through the earlier of consummation of the Initial Business Combination and our liquidation.

For the three and six months ended June 30, 2023, $2,100 and $3,500, respectively, has been incurred and paid under this agreement. For the three and six months ended June 30, 2022, $39,000 and $78,000, respectively, has been incurred and paid under this agreement.

Note 4 — Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement signed on or before the date of the prospectus for the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were entitled to a deferred underwriting commissions of $0.50 per Unit, or $7,187,500 from the closing of the IPO. In association with the redemption of the Company’s Class A ordinary shares on January 12, 2023, the underwriters have agreed to a reduced commission of $1,500,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

The Company treated the $5,687,500 reduction of the deferred underwriting commissions as a reversal of offering costs of the IPO. As such, $270,725 of recovery of offering costs allocated to warrants is reported on the condensed statement of operations under other income and $5,416,775 of recovery of deferred underwriting commissions is reported on the condensed statement of changes in redeemable ordinary shares and shareholders’ deficit under recovery of deferred underwriter commission.

Business Combination Agreement

As disclosed in Note 1, on October 20, 2022, the Company entered into a Business Combination Agreement by and among Prize, Merger Sub, PubCo, HoldCo and, for certain limited purposes, AGH.

Shareholder Approvals

As discussed in Note 1, on January 12, 2023, the Company held the Meeting at which the shareholders approved the Extension Proposal to extend the date by which the Company must complete its Initial Business Combination from January 18, 2023, to July 18, 2023. Additionally, the shareholders approved the Clarification Proposal to acknowledge and clarify that pursuant to the Articles, approval of the Company’s Initial Business Combination requires an ordinary resolution.

In connection with the vote to approve the Extension Proposal and Clarification Proposal, the holders of 14,118,106 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of approximately $146 million.

As discussed in Note 1, on June 29, 2023, the Company’s shareholders approved the proposal to extend the date by which the Company must complete its Initial Business Combination from July 18, 2023, to January 18, 2024. In connection with the vote to approve the Extension Proposal, the holder of one Class A ordinary share of the Company exercised their right to redeem their share for a total redemption amount of $11.

Note 5 — Shareholders’ Deficit

Preference Shares — The Company is authorized to issue 2,000,000 shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

Ordinary Shares

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were 4,000,000 and -0- shares of Class A ordinary shares issued and outstanding (excluding 256,893 and 14,375,000 shares of Class A ordinary shares subject to possible redemption), respectively.

14

As discussed in Note 1, on January 24, 2023, the Company received the Notice from the Staff of Nasdaq indicating that the Company was not in compliance with certain requirements of the Nasdaq Listing Rules.  As part of the Company’s plan to regain compliance with the Nasdaq Listing Rules, on February 28, 2023, the Sponsor converted  4,000,000 Class B ordinary shares to Class A ordinary shares on a 1:1 basis. The Sponsor’s converted Class A ordinary shares are not subject to redemptions and have no rights to funds held in the Trust Account.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 1,031,250 and 5,031,250 shares of Class B ordinary shares outstanding, respectively.

Holders of shares of Class A ordinary shares and shares of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders.

The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the Initial Business Combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the IPO plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.

Note 6 — Warrant Liabilities

Warrants —The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such shares of ordinary shares. Notwithstanding the foregoing, if a registration statement covering the shares of ordinary shares issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of an Initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation.

Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00

Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):

• in whole and not in part;

• at a price of $0.01 per warrant;

• upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the “30-day redemption period”; and

• if, and only if, the last reported sale price (the “closing price”) of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders.

We will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Except as set forth below, none of the private placement warrants will be redeemable by us so long as they are held by our Sponsor, Canto, Cohen or their permitted transferees.

The “fair market value” of our Class A ordinary shares for the above purpose shall mean the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. We will provide our warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the private placement warrants.

No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. Please see the section entitled “Description of Securities — Warrants — Public Shareholders’ Warrants” for additional information.

15

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The Private Warrants are identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Warrants and the shares of ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The exercise price and number of shares of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete an Initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if the Company issues additional shares of ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of an Initial Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an Initial Business Combination on the date of the consummation of an Initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates an Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of ordinary shares or equity-linked securities.

The Company accounts for the Public Warrants and Private Placement Warrants as liabilities in accordance with the guidance contained in ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability.

Additionally, certain adjustments to the settlement amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815 — 40, and thus the Private Placement Warrants are not considered indexed to the Company’s own share and not eligible for an exception from derivative accounting.

The accounting treatment of derivative financial instruments required that the Company record a derivative liability upon issuance of the warrants at the closing of the IPO. Accordingly, the Company classified each warrant as a liability at its fair value. The Public Warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined with the assistance of a professional independent valuation firm. The warrant liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification of the warrants at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

Note 7 — Fair Value Measurements

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

At June 30, 2023 and December 31, 2022, assets held in the Trust Account were comprised of U.S. Money Market Funds primarily invested in U.S. Treasury obligations.

At June 30, 2023 and December 31, 2022, there were 7,187,500 Public Warrants and 6,100,000 Private Placement Warrants outstanding.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis indicating the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

16

JUNE 30, 2023:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	2,917,376	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	179,688	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	152,500	$	—

DECEMBER 31, 2022:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	148,742,661	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	718,750	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	610,000	$	—

At June 30, 2023 and December 31, 2022 the fair value of the Public Warrants was based on quoted market prices in an active market. The Company considers the Private Placement Warrants to be economically equivalent to the Public Warrants. As such, the fair value of the Private Placement Warrants is measured by reference to the trading price of the Public Warrants; which is considered a Level 2 fair value measurement.

At June 30, 2023 and December 31, 2022, the Public Warrants and Private Placement Warrants were valued at $0.025 and $0.10, respectively.

Note 8 - Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based on this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

On July 17, 2023, the Company (“Rose Hill”), Prize and AGH, entered into Amendment No. 1 to Business Combination Agreement (the “Amendment”), pursuant to which the parties amended the Business Combination Agreement to (i) clarify the amount of shares to be issued by Merger Sub to Prize in connection with the Pre-Closing Restructuring, (ii) permit Prize and AGH to solicit, initiate, enter into or continue discussions, negotiations or transactions with, or encourage or respond to any inquiries or proposals by, or provide any information to, any Person, concerning any merger, consolidation, sale of ownership interests and/or substantial portion of the assets, recapitalization or similar transaction of, by or involving Prize, HoldCo, PubCo or Merger Sub and terminate the Business Combination Agreement to enter into a definitive agreement with respect to any such transaction, in each case, until such time as Rose Hill, Prize and applicable investors agree in writing to the key economic terms of subscription agreements with respect to PIPE investments that, if consummated, would result in the receipt of proceeds of at least $50.0 million in the aggregate to PubCo in connection with the Closing, and (iii) extend the date by which either Rose Hill, Prize or AGH can terminate the Business Combination Agreement, if the transactions contemplated thereby have not been consummated by such date, from July 18, 2023 to October 18, 2023.

On July 26, 2023, the Company received a delisting determination letter (the “Determination Letter”) from the Staff notifying the Company that (i) it had not regained compliance with Nasdaq Listing Rule 5550(a)(4) requiring a minimum of 500,000 publicly held shares and (ii) the Company’s Class A ordinary shares, warrants and units are subject to delisting from The Nasdaq Capital Market. The Determination Letter further noted that, unless the Company requests an appeal of the Staff’s determination with the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s Class A ordinary shares, warrants and units on The Nasdaq Capital Market will be suspended at the opening of business on August 4, 2023, and a Form 25-NSE would be filed with the SEC removing the Company’s securities from listing and registration on The Nasdaq Capital Market.

With respect to the Determination Letter, on August 1, 2023, the Company requested a hearing before the Panel to appeal the Staff’s determination. The hearing before the Panel is expected to occur on October 5, 2023. The hearing request will stay the suspension and delisting of the Company’s securities pending a decision by the Panel. The Panel may, in its discretion, grant the Company an additional compliance period to regain compliance and maintain its Nasdaq listing; however, there can be no assurance that the Panel will grant such additional time.

On July 31, 2023, Rose Hill, the Sponsor, Prize and Prize SuperFoods (“PubCo”), entered into Amendment No. 1 to the Sponsor Support Agreement (the “Amendment”), pursuant to which the parties amended the Sponsor Support Agreement to reflect the parties mutual agreement at the time the Business Combination Agreement, dated as of October 19, 2022, by and among Rose Hill, GHC and, for certain limited purposes, Alejandro García-Huidobro Empresario, an individual (the “Business Combination Agreement”), was executed that the Sponsor will forfeit 3,631,250 Rose Hill ordinary shares immediately prior to the transactions contemplated by the Business Combination Agreement such that the Sponsor will own 1,400,000 Rose Hill ordinary shares immediately following the forfeiture, 700,000 of which are subject to vesting conditions, as described in the Sponsor Support Agreement.

17

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this Quarterly Report to “we,” “us” or the “Company” refer to Rose Hill Acquisition Corporation References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refers to Rose Hill Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” including statements relating to our financial position, business strategy and the plans and objectives of management for future operations; our ability to complete an Initial Business Combination, including the Business Combination with Prize; our expectations regarding the Business Combination with Prize, including the expected benefits of the business combination and future value creation; our expectations regarding the cost of pursuing an Initial Business Combination; our public securities’ potential liquidity and trading; our use of proceeds not held in the Trust Account or available to us from interest income on the Trust Account balance; our ability to continue our listing on Nasdaq; our future liquidity and capital requirements; our ability to continue as a going concern; our ability to obtain additional financing to complete our Initial Business Combination; our expectations regarding future issuances of ordinary shares in connection with an Initial Business Combination; our expectations around the performance of a prospective target business or businesses; our ability to select an appropriate target business or businesses; and our expectations and estimates regarding certain tax and accounting matters, including the impact on our financial statements are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed on March 31, 2023 with the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

Company was incorporated on March 29, 2021, as a Cayman Islands exempted company. The Company was formed for the purpose of entering into an Initial Business Combination with one or more businesses.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an Initial Business Combination will be successful.

Business Combination with Prize

Business Combination Agreement

On October 20, 2022, we entered into a Business Combination Agreement with Prize and, for certain limited purposes, AGH, pursuant to which, and subject to the terms and conditions set forth therein, prior to the consummation of the Business Combination, (i) Prize caused to be incorporated under the laws of the Cayman Islands, (a) an exempted company with limited liability to serve as “PubCo” for all purposes under the Business Combination Agreement and (b) an exempted company with limited liability to serve as “Merger Sub” for all purposes under the Business Combination Agreement, (ii) Prize and AGH caused to be incorporated under the laws of Chile, a simplified stock corporation that will serve as “HoldCo” for all purposes under the Business Combination Agreement, in each case, as a direct wholly owned subsidiary of Prize and (iii) Prize and AGH will consummate the Pre-Closing Restructuring pursuant to which, among other things, all subsidiaries of Prize will become direct or indirect subsidiaries of HoldCo, HoldCo will become a wholly owned subsidiary of Merger Sub, and Merger Sub will become a wholly owned subsidiary of Prize.

Following the Pre-Closing Restructuring, at the closing of the Business Combination, (i) the Company will be merged with and into PubCo with PubCo continuing as the surviving entity of the First Merger and (ii) subsequent to the First Merger, Merger Sub will be merged with and into PubCo with PubCo continuing as the surviving entity of the Second Merger.

The terms of the Business Combination Agreement, which contains customary representations and warranties, covenants, closing conditions and other terms relating to the Business Combination, are summarized below. Capitalized terms used in this Quarterly Report but not otherwise defined herein have the meanings given to them in the Business Combination Agreement, which is included as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2022, filed on March 31, 2023.

18

On July 17, 2023, Rose Hill, Prize and AGH, entered into the Amendment, pursuant to which the parties amended the Business Combination Agreement to (i) clarify the amount of shares to be issued by Merger Sub to Prize in connection with the Pre-Closing Restructuring, (ii) permit Prize and AGH to solicit, initiate, enter into or continue discussions, negotiations or transactions with, or encourage or respond to any inquiries or proposals by, or provide any information to, any Person, concerning any merger, consolidation, sale of ownership interests and/or substantial portion of the assets, recapitalization or similar transaction of, by or involving Prize, HoldCo, PubCo or Merger Sub and terminate the Business Combination Agreement to enter into a definitive agreement with respect to any such transaction, in each case,  until such time as Rose Hill, Prize and applicable investors agree in writing to the key economic terms of subscription agreements with respect to PIPE investments that, if consummated, would result in the receipt of proceeds of at least $50.0 million in the aggregate to PubCo in connection with the Closing, and (iii) extend the date by which either Rose Hill, Prize or AGH can terminate the Business Combination Agreement, if the transactions contemplated thereby have not been consummated by such date, from July 18, 2023 to October 18, 2023.

Consideration

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the First Merger, (i) each Rose Hill ordinary share that is issued and outstanding immediately prior to the First Merger will be converted into one validly issued, fully paid and non-assessable PubCo ordinary share, and (ii) all outstanding warrants to purchase ordinary shares of Rose Hill will be converted into warrants to purchase the same number of PubCo ordinary shares and all rights with respect to Rose Hill ordinary shares under such Rose Hill warrants will be converted into rights with respect to the applicable PubCo ordinary shares.

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the Second Merger, each Merger Sub ordinary share that is issued and outstanding immediately prior to the Second Merger will be converted into a number of PubCo ordinary shares equal to the quotient of (i) the Equity Value, divided by (ii) the number of Merger Sub ordinary shares that are issued and outstanding immediately prior to the Second Merger, divided by (iii) $10.00. The “Equity Value” under the Business Combination Agreement is an amount equal to (i) $328,000,000, minus (ii) the lesser of (a) the Specified Transaction Expenses of Prize and the Company (other than those expenses incurred in respect of obtaining an equity line of credit or similar financing arrangement to be in place and available to PubCo as of the Closing of the Business Combination) and (b) $10,000,000.

In the event that the Specified Transaction Expenses exceed $10,000,000, then the number of PubCo ordinary shares otherwise issuable to the Sponsor under the Business Combination Agreement will be decreased by a number of shares equal to the amount of such excess divided by $10.00.

Earn-Out Shares

If, at any time following the Closing, the VWAP of PubCo ordinary shares is greater than or equal to (a) $18.00, (b) $22.00, (c) $26.00, or (d) $30.00 in each case, over any thirty (30) days on which the PubCo ordinary shares are tradeable on Nasdaq within any consecutive forty-five (45) Trading Day period, then PubCo will issue 2,948,800 Earn-Out Shares to Prize after the occurrence of each such consecutive forty-five (45) Trading Day period. For the avoidance of doubt, Prize may be entitled to receive a maximum of 11,795,200 Earn-Out Shares in the aggregate in respect of the occurrence of all four Earn-Out Events.

Registration Rights and Lock-up Agreement

In connection with the Closing of the Business Combination Agreement, PubCo, the Sponsor, Prize and certain other parties thereto will enter the Registration Rights and Lock-Up Agreement, which, among other things, (i) effective as of the Closing, terminates and replaces the current registration rights agreement, dated as of October 13, 2021, by and among Rose Hill, the Sponsor and the other parties thereto, (ii) provides that PubCo will be obligated to file a registration statement to register the resale of certain PubCo ordinary shares held by Sponsor, Prize and certain other parties thereto, at the consummation of the business combination, (iii) provides certain parties thereto including Prize, certain demand and piggyback registration rights, and (iv) provides for certain restrictions on transfer relating to PubCo ordinary shares and warrants to purchase PubCo ordinary shares held by Sponsor, Prize and certain parties thereto.

Company Support Agreement

In connection with the execution of the Business Combination Agreement, Rose Hill, Prize and AGH have entered into the Company Support Agreement pursuant to which, among other things, AGH has agreed to (a) vote his Merger Sub ordinary shares in favor of the approval and adoption of the Business Combination Agreement and the Business Combination and (b) certain transfer restrictions with respect to his Merger Sub ordinary shares and shares of Prize.

Sponsor Support Agreement

In connection with the execution of the Business Combination Agreement, the Sponsor entered into the Sponsor Support Agreement pursuant to which the Sponsor has agreed, among other things, to (i) certain restrictions on transfer relating to its ordinary shares of Rose Hill prior to the Closing as set forth therein, (ii) not redeem any of its shares of Rose Hill in connection with the vote to approve the Business Combination or any proposal to extend the date by which Rose Hill must complete an Initial Business Combination, (iii) vote in favor of the Mergers and the other transactions and against any alternative transaction, (iv) waive certain anti-dilution provisions contained in Rose Hill’s Articles in connection with the Mergers and (v) subject a certain number of its Class B ordinary shares of Rose Hill to vesting.

Sponsor Support Agreement Amendment

On July 31, 2023, Rose Hill, the Sponsor, Prize and Prize SuperFoods (“PubCo”), entered into Amendment No. 1 to the Sponsor Support Agreement (the “Amendment”), pursuant to which the parties amended the Sponsor Support Agreement to reflect the parties mutual agreement at the time the Business Combination Agreement, dated as of October 19, 2022, by and among Rose Hill, GHC and, for certain limited purposes, Alejandro García-Huidobro Empresario, an individual (the “Business Combination Agreement”), was executed that the Sponsor will forfeit 3,631,250 Rose Hill ordinary shares immediately prior to the transactions contemplated by the Business Combination Agreement such that the Sponsor will own 1,400,000 Rose Hill ordinary shares immediately following the forfeiture, 700,000 of which are subject to vesting conditions, as described in the Sponsor Support Agreement.

Standby Equity Purchase Agreement

In connection with the execution of the Business Combination Agreement and for purposes of obtaining equity financing on behalf of PubCo at Closing, Prize entered into a standby equity purchase agreement the Investor, pursuant to which, among other things, at the Closing, PubCo will have the right (but not the obligation) to sell to the Investor, and the Investor will purchase from PubCo, up to $150,000,000 of PubCo ordinary shares at a purchase price of 97% of the Market Price (as defined therein) of the PubCo ordinary shares, subject to the terms and conditions set forth therein.

For additional information regarding the Business Combination and the transactions contemplated thereby, see the Current Report on Form 8-K filed with the SEC on October 25, 2022.

19

Other than as specifically discussed, this Quarterly Report does not assume the closing of the Business Combination.

Notice of Delisting

On January 24, 2023, the Company received the Notice from the Staff of Nasdaq indicating that the Company was not in compliance with certain requirements of the Nasdaq Listing Rules. On March 24, 2023, Nasdaq granted the Company an extension until July 24, 2023, by which time the Company must file with the SEC and Nasdaq a public document showing that it has regained compliance with the Nasdaq Listing Rules. If the Company is unable to regain compliance with the Nasdaq Listing Rules by July 24, 2023, it may be subject to delisting procedures as set forth in the Nasdaq continued listing rules.

The Company cannot assure you that it will be successful in regaining compliance with the Nasdaq continued listing requirements and that its securities will continue to be listed on Nasdaq in the future or prior to the Company’s Initial Business Combination. In order to continue listing the Company’s securities on the Nasdaq prior to its Initial Business Combination, the Company must regain and continue to maintain certain financial, distribution and share price levels. Generally, the Company must maintain a minimum market capitalization (generally $35,000,000) and a minimum number of holders of our securities (generally 300 public holders).

On February 28, 2023, the Sponsor converted 4,000,000 of its Class B ordinary shares to Class A ordinary shares of the Company on a 1:1 basis as part of the Company’s plan to regain compliance with the Nasdaq Listing Rules. As a result, the Company’s market capitalization as of June 30, 2023, was $42,186,711. The newly converted Class A ordinary shares held by the Sponsor are not subject to redemptions and have no rights to funds held in the Trust Account.

On July 26, 2023, the Company received a delisting determination letter (the “Determination Letter”) from the Staff notifying the Company that (i) it had not regained compliance with Nasdaq Listing Rule 5550(a)(4) requiring a minimum of 500,000 publicly held shares and (ii) the Company’s Class A ordinary shares, warrants and units are subject to delisting from The Nasdaq Capital Market. The Determination Letter further noted that, unless the Company requests an appeal of the Staff’s determination with the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s Class A ordinary shares, warrants and units on The Nasdaq Capital Market would be suspended at the opening of business on August 4, 2023, and a Form 25-NSE would be filed with the SEC removing the Company’s securities from listing and registration on The Nasdaq Capital Market.

With respect to the Determination Letter, on August 1, 2023, the Company requested a hearing before the Panel to appeal the Staff’s determination. The hearing before the Panel is expected to occur on October 5, 2023. The hearing request will stay the suspension and delisting of the Company’s securities pending a decision by the Panel. The Panel may, in its discretion, grant the Company an additional compliance period to regain compliance and maintain its Nasdaq listing; however, there can be no assurance that the Panel will grant such additional time.

Results of Operations

As of June 30, 2023, the Company had not commenced any operations. All activity through June 30, 2023, relates to the Company’s formation and IPO, and since the IPO, the search for a prospective Initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of earnings from the proceeds derived from the Initial Public Offering.

For the three months ended June 30, 2023, we had a net loss of $409,427 which consists of operating expenses of $909,264 partially offset by earnings on investments held in trust account and other interest of $34,775 and change in fair value of warrants of $465,062.

For the three months ended June 30, 2022, we had a net income of $128,347 which consists of operating expenses of $325,978, Interest income on investments held in trust account and other interest of $198,121 and change in fair value of warrants of $256,204.

For the six months ended June 30, 2023, we had a net income of $531,910 which consists of operating expenses of $1,170,972 partially offset by earnings on investments held in trust account and other interest of $435,595, recovery of offering costs allocated to warrants of $270,725 and change in fair value of warrants of $996,562.

For the six months ended June 30, 2022, we had a net income of $2,809,665 which consists of operating expenses of $611,146, Interest income on investments held in trust account and other interest of $212,901 and change in fair value of warrants of $3,207,910.

Liquidity and Capital Resources

For the period ended June 30, 2023, there was $341,770 cash provided by operating activities.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

At June 30, 2023, we had cash of $3,577 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

In order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post business combination entity at a price of $1.25 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2023 and December 31, 2022, the Company had no outstanding borrowings under the Working Capital Loans. In addition, the Company does not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

In connection with the Company’s shareholder vote to approve the Extension Proposal on January 12, 2023, the holders of 14,118,106 of our Class A ordinary shares originally issued in our IPO exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of approximately $146 million.

On June 29, 2023, the Company’s shareholders approved the proposal to extend the date by which the Company must complete its Initial Business Combination from July 18, 2023, to January 18, 2024. In connection with the vote to approve the Extension Proposal, the holder of one Class A ordinary share of the Company exercised their right to redeem their share for a total redemption amount of $11.

20

We may need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating and completing a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our business Combination, in which case we may issue additional securities or incur debt in connection with such business combination. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed financial statements. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

The underwriters were entitled to a deferred underwriting commission of $0.50 per Unit, or $7,187,500 from the closing of the IPO. In association with the redemption of the Company’s Class A ordinary shares on January 12, 2023, the underwriters have agreed to a reduced commission of $1,500,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

The Company treated the $5,687,500 reduction of the deferred underwriting commissions as a reversal of offering costs of the IPO. As such, $270,725 of recovery of offering costs allocated to warrants is reported on the condensed statement of operations and $5,416,775 of recovery of deferred underwriting commissions is reported on the condensed statement of changes in redeemable ordinary shares and shareholders’ deficit.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

Critical Accounting Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have not identified any critical accounting estimates.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act, we are not required to provide the information under this item.

21

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of June 30, 2023 to ensure that information required to be disclosed in reports that are filed or submitted under the Exchange Act are (1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and (2) accumulated and communicated to Management, including the certifying officers, as appropriate to allow timely decisions regarding required disclosures. As previously reported in our 2022 Annual Report on Form 10-K, management concluded that the Company did not maintain adequate controls over the classification of the statement of cash flows. We identified material weaknesses in our internal control over financial reporting. As previously reported in our 2022 Annual Report on Form 10-K, management concluded that the Company did not maintain adequate controls over the classification of the statement of cash flows. This material weakness continues to exist at June 30, 2023.

Remediation Plan

Management plans to remediate the material weakness identified above by enhancing our processes to identify and appropriately apply applicable accounting requirements and increased communication among our personnel and third-party professionals with whom we consult regarding accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control Over Financial Reporting

Other than the matters discussed above, there were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

22

PART II — OTHER INFORMATION

Item 6. Exhibits.

The following exhibits are filed or furnished as a part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

10.1	Amendment No. 1 to The Sponsor Support Agreement, dated as of July 31, 2023, by and among Rose Hill Acquisition Corporation, Rose Hill Sponsor LLC, Inversiones e Inmobilaria GHC Ltda and Prize SuperFoods (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on August 4, 2023.
31.1*	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3*	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4*	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.3**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.4**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document, which is contained in Exhibit 101).

*	Filed herewith.
**	Furnished herewith.

23

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ROSE HILL ACQUISITION CORPORATION
Date: August 15, 2023	By:	/s/ Felipe Canales
	Name:	Felipe Canales
	Title:	Co-Chief Executive Officer and Director
		(Principal Executive Officer)
Date: August 15, 2023	By:	/s/ Marco Simental
	Name:	Marco Simental
	Title:	Co-Chief Executive Officer and Director
		(Principal Executive Officer)
Date: August 15, 2023	By:	/s/ Albert Hill IV
	Name:	Albert Hill IV
	Title:	Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)
Date: August 15, 2023	By:	/s/ Juan Jose Rosas
	Name:	Juan Jose Rosas
	Title:	Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

24

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Felipe Canales, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, of Rose Hill Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 15, 2023	By:	/s/ Felipe Canales
		Felipe Canales
		Co-Chief Executive Officer and Director
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marco Simental, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, of Rose Hill Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 15, 2023	By:	/s/ Marco Simental
		Marco Simental
		Co-Chief Executive Officer and Director
		(Principal Executive Officer)

EX-31.3

EXHIBIT 31.3

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Albert Hill IV, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, of Rose Hill Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 15, 2023	By:	/s/ Albert Hill IV
		Albert Hill IV
		Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-31.4

EXHIBIT 31.4

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Juan Jose Rosas, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, of Rose Hill Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 15, 2023	By:	/s/ Juan Jose Rosas
		Juan Jose Rosas
		Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rose Hill Acquisition Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Felipe Canales, Co-Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2023	By:	/s/ Felipe Canales
		Felipe Canales
		Co-Chief Executive Officer and Director
		(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rose Hill Acquisition Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marco Simental, Co-Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2023	By:	/s/ Marco Simental
		Marco Simental
		Co-Chief Executive Officer and Director
		(Principal Executive Officer)

EX-32.3

EXHIBIT 32.3

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rose Hill Acquisition Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Albert Hill IV, Co-Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2023	By:	/s/ Albert Hill IV
		Albert Hill IV
		Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-32.4

EXHIBIT 32.4

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rose Hill Acquisition Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Juan Jose Rosas, Co-Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2023	By:	/s/ Juan Jose Rosas
		Juan Jose Rosas
		Co-Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 11, 2023
Entity Listings [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Document Transition Report	false
Entity File Number	001-40900
Entity Registrant Name	ROSE HILL ACQUISITION CORPORATION
Entity Central Index Key	0001870129
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	981 Davis Dr NW
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30327
City Area Code	607
Local Phone Number	279 2371
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Units [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	ROSEU
Security Exchange Name	NASDAQ
Class A Ordinary Shares [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	ROSE
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		4,256,893
Redeemable Warrants [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
Trading Symbol	ROSEW
Security Exchange Name	NASDAQ
Class B Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		1,031,250

XML

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 3,577	$ 96,119
Prepaid expenses	0	104,905
Due from affiliates	$ 25,000	$ 25,000
Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration]	srt:AffiliatedEntityMember	srt:AffiliatedEntityMember
Total current assets	$ 28,577	$ 226,024
NON - CURRENT ASSETS
Investments held in Trust Account	2,917,376	148,742,661
Total Non - Current Assets	2,917,376	148,742,661
TOTAL ASSETS	2,945,953	148,968,685
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,196,239	223,997
Total current liabilities	1,196,239	223,997
LONG TERM LIABILITIES
Derivative warrant liabilities	332,188	1,328,750
Deferred underwriting fee payable	1,500,000	7,187,500
Total long-term liabilities	1,832,188	8,516,250
Total liabilities	3,028,427	8,740,247
COMMITMENTS AND CONTINGENCIES (NOTE 4)
Class A ordinary shares subject to possible redemption, $0.0001 par value, 256,893 and 14,375,000 shares at redemption value at June 30, 2023 and December 31, 2022, respectively	2,917,376	148,742,661
SHAREHOLDERS' DEFICIT
Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2023 and December 31, 2022 respectively	0	0
Additional paid-in capital	0	0
Accumulated deficit	(3,000,353)	(8,514,726)
Total shareholders' deficit	(2,999,850)	(8,514,223)
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT	2,945,953	148,968,685
Class A Ordinary Shares [Member]
SHAREHOLDERS' DEFICIT
Ordinary shares	400	0
Class B Ordinary Shares [Member]
SHAREHOLDERS' DEFICIT
Ordinary shares	$ 103	$ 503

XML

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
SHAREHOLDERS' DEFICIT
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized (in shares)	2,000,000	2,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Ordinary shares, shares outstanding (in shares)	4,000,000
Class A Ordinary Shares [Member]
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT
Ordinary shares subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption (in shares)	256,893	14,375,000
SHAREHOLDERS' DEFICIT
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares,, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, shares issued (in shares)	4,000,000	0
Ordinary shares, shares outstanding (in shares)	4,000,000	0
Class B Ordinary Shares [Member]
SHAREHOLDERS' DEFICIT
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares,, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	1,031,250	5,031,250
Ordinary shares, shares outstanding (in shares)	1,031,250	5,031,250

XML

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
OPERATING EXPENSES
General and administrative expenses	$ 909,264	$ 325,978	$ 1,170,972	$ 611,146
Loss from operations	(909,264)	(325,978)	(1,170,972)	(611,146)
Other income:
Earnings on investments held in Trust Account and other interest	34,775	198,121	435,595	212,901
Recovery of offering costs allocated to warrants	0	0	270,725	0
Change in fair value of warrants	465,062	256,204	996,562	3,207,910
Total other income	499,837	454,325	1,702,882	3,420,811
Net (loss) income	$ (409,427)	$ 128,347	$ 531,910	$ 2,809,665
Weighted average shares outstanding basic (in shares)	5,288,144	19,406,250	6,068,150	19,406,250
Weighted average shares outstanding not subject to redemption, diluted (in shares)	5,288,144	19,406,250		19,406,250
Common Stock Subject to Possible Redemption [Member]
Other income:
Weighted average shares outstanding basic (in shares)	256,894
Class A Ordinary Shares [Member]
Other income:
Weighted average shares outstanding basic (in shares)				5,031,250
Class A Ordinary Shares [Member] | Common Stock Subject to Possible Redemption [Member]
Other income:
Weighted average shares outstanding of Class A ordinary shares subject to redemption (in shares)	256,894	14,375,000	1,036,900	14,375,000
Weighted average shares outstanding basic (in shares)	256,894	14,375,000	1,036,900	14,375,000
Basic net income per share not subject to redemption (in dollars per share)	$ 0.05	$ 0.01	$ 0.43	$ 0.15
Weighted average shares outstanding not subject to redemption, diluted (in shares)	256,894	14,375,000		14,375,000
Diluted net income per share not subject to redemption (in dollars per share)	$ 0.05	$ 0.01	$ 0.43	$ 0.15
Class B Ordinary Shares [Member]
Other income:
Weighted average shares outstanding basic (in shares)	5,031,250	5,031,250	5,031,250	5,031,250
Basic net income per share not subject to redemption (in dollars per share)	$ (0.08)	$ 0	$ 0.02	$ 0.13
Weighted average shares outstanding not subject to redemption, diluted (in shares)	5,031,250	5,031,250		5,031,250
Diluted net income per share not subject to redemption (in dollars per share)	$ (0.08)	$ 0	$ 0.02	$ 0.13
Common Class A and B [Member]
Other income:
Weighted average shares outstanding basic (in shares)	5,031,250	5,031,250	5,031,250	5,031,250
Basic net income per share not subject to redemption (in dollars per share)	$ (0.08)	$ 0	$ 0.02	$ 0.13
Weighted average shares outstanding not subject to redemption, diluted (in shares)	5,031,250	5,031,250	5,031,250	5,031,250
Diluted net income per share not subject to redemption (in dollars per share)	$ (0.08)	$ 0	$ 0.02	$ 0.13

XML

CONDENSED STATEMENTS OF CHANGES IN REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Ordinary Shares [Member] Class B Ordinary Shares [Member]	Class A Ordinary Shares Subject to Possible Redeemable [Member] Class A Ordinary Shares [Member]	Class A Ordinary Shares Not Subject to Possible Redemption [Member] Class B Ordinary Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2021	$ 503	$ 146,625,000	$ 0	$ 0	$ (12,607,205)	$ (12,606,702)
Beginning balance (in shares) at Dec. 31, 2021	5,031,250	14,375,000	0
Redemptions (in shares)	0
Recovery of Deferred Underwriter Commissions	$ 0
Remeasurement of redeemable Class A ordinary shares to redemption value	0	$ 17,509	$ 0	0	(17,509)	(17,509)
Net income	0	0	0	0	2,681,318	2,681,318
Ending balance at Mar. 31, 2022	$ 503	$ 146,642,509	$ 0	0	(9,943,396)	(9,942,893)
Ending balance (in shares) at Mar. 31, 2022	5,031,250	14,375,000	0
Beginning balance at Dec. 31, 2021	$ 503	$ 146,625,000	$ 0	0	(12,607,205)	(12,606,702)
Beginning balance (in shares) at Dec. 31, 2021	5,031,250	14,375,000	0
Net income						2,809,665
Ending balance at Jun. 30, 2022	$ 503	$ 146,840,491	$ 0	0	(10,013,031)	(10,012,528)
Ending balance (in shares) at Jun. 30, 2022	5,031,250	14,375,000	0
Beginning balance at Mar. 31, 2022	$ 503	$ 146,642,509	$ 0	0	(9,943,396)	(9,942,893)
Beginning balance (in shares) at Mar. 31, 2022	5,031,250	14,375,000	0
Remeasurement of redeemable Class A ordinary shares to redemption value	$ 0	$ 197,982	$ 0	0	(197,982)	(197,982)
Net income	0	0	0	0	128,347	128,347
Ending balance at Jun. 30, 2022	$ 503	$ 146,840,491	$ 0	0	(10,013,031)	(10,012,528)
Ending balance (in shares) at Jun. 30, 2022	5,031,250	14,375,000	0
Beginning balance at Dec. 31, 2022	$ 503	$ 148,742,661	$ 0	0	(8,514,726)	(8,514,223)
Beginning balance (in shares) at Dec. 31, 2022	5,031,250	14,375,000	0
Redemptions	$ 0	$ (146,259,586)	$ 0	0	0	0
Redemptions (in shares)	0	(14,118,106)	0
Recovery of Deferred Underwriter Commissions	$ 0	$ 0	$ 0	0	5,416,775	5,416,775
Remeasurement of redeemable Class A ordinary shares to redemption value	0	399,927	0	0	(399,927)	(399,927)
Reclassification of Class B shares to Class A shares	$ (400)	$ 0	$ 400	0	0	0
Reclassification of Class B shares to Class A shares (in shares)	(4,000,000)	0	4,000,000
Net income	$ 0	$ 0	$ 0	0	941,337	941,337
Ending balance at Mar. 31, 2023	$ 103	$ 2,883,002	$ 400	0	(2,556,541)	(2,556,038)
Ending balance (in shares) at Mar. 31, 2023	1,031,250	256,894	4,000,000
Beginning balance at Dec. 31, 2022	$ 503	$ 148,742,661	$ 0	0	(8,514,726)	(8,514,223)
Beginning balance (in shares) at Dec. 31, 2022	5,031,250	14,375,000	0
Net income						531,910
Ending balance at Jun. 30, 2023	$ 103	$ 2,917,376	$ 400	0	(3,000,353)	(2,999,850)
Ending balance (in shares) at Jun. 30, 2023	1,031,250	256,893	4,000,000
Beginning balance at Mar. 31, 2023	$ 103	$ 2,883,002	$ 400	0	(2,556,541)	(2,556,038)
Beginning balance (in shares) at Mar. 31, 2023	1,031,250	256,894	4,000,000
Redemptions		$ (11)
Redemptions (in shares)		(1)
Remeasurement of redeemable Class A ordinary shares to redemption value	$ 0	$ 34,385	$ 0	0	(34,385)	(34,385)
Net income	0	0	0	0	(409,427)	(409,427)
Ending balance at Jun. 30, 2023	$ 103	$ 2,917,376	$ 400	$ 0	$ (3,000,353)	$ (2,999,850)
Ending balance (in shares) at Jun. 30, 2023	1,031,250	256,893	4,000,000

XML

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 531,910	$ 2,809,665
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Earnings on investments held in Trust Account	0	(212,762)
Recovery of offering costs allocated to warrants	(270,725)	0
Change in fair value of warrants	(996,562)	(3,207,910)
Changes in operating assets and liabilities:
Prepaid expenses	104,905	153,786
Accounts payable and accrued expenses	972,242	136,841
Net cash provided by (used in) operating activities	341,770	(320,380)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash withdrawn from Trust Account in connection with redemption	146,259,597	0
Reinvestment of dividend income on Trust Account	(434,312)	0
Net cash provided by investing activities	145,825,285	0
CASH FLOWS FROM FINANCING ACTIVITIES
Redemption of Class A common stock subject to possible redemption	(146,259,597)	0
Net cash used in financing activities	(146,259,597)	0
NET CHANGE IN CASH	(92,542)	(320,380)
CASH, BEGINNING OF PERIOD	96,119	658,747
CASH, END OF PERIOD	3,577	338,367
Non-cash investing and financing activities:
Reclassification of Class B shares to Class A shares	400	0
Impact of the recovery of deferred commission by the underwriters	5,416,775	0
Remeasurement of redeemable Class A ordinary shares to redemption value	$ 434,312	$ 215,491

XML

Description of Organization and Business Operations

6 Months Ended

Jun. 30, 2023

Description of Organization and Business Operations [Abstract]

Description of Organization and Business Operations

Note 1 — Description of Organization and Business Operations

Rose Hill Acquisition Corporation (the “Company”) was incorporated in the Cayman Islands on March 29, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (an “Initial Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had not commenced any operations. Activity through June 30, 2023, relates to the Company’s formation and initial public offering (“IPO”), which is described below and, since the IPO, the search for a prospective Initial Business Combination. The Company will not generate any operating revenues until after the completion of its Initial Business Combination, at the earliest. The Company generates non-operating income in the form of earnings on investments from the proceeds derived from the IPO.

The registration statement for the Company’s IPO was declared effective on October 13, 2021. On October 18, 2021, the Company consummated the IPO of 12,500,000 units (“Units”) with respect to the Class A ordinary shares included in the units being offered (the “Public Shares”) at $10.00 per unit generating gross proceeds of $125,000,000.

The Company had until January 18, 2023, 15 months from the closing of the IPO to complete an Initial Business Combination. On January 12, 2023, the shareholders approved a proposal, as a special resolution, to amend the Company’s amended and restated memorandum and articles of association (“Articles”) to extend the date by which the Company must complete its Initial Business Combination from January 18, 2023, to July 18, 2023 (“Extension Proposal”). Additionally, the shareholders approved a proposal, as a special resolution, to amend the Articles to acknowledge and clarify that pursuant to the Articles, approval of the Company’s Initial Business Combination requires an ordinary resolution (“Clarification Proposal”). In connection with the vote to approve the Extension Proposal and Clarification Proposal, the holders of 14,118,106 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of approximately $146,000,000 million. Following such redemption, the amount of funds remaining in the Company’s trust account was approximately $2.8 million.

On June 29, 2023, the Company held an extraordinary general meeting of shareholders (the “Meeting”). The Company’s shareholders approved the proposal, as a special resolution, to amend the Articles to extend the date by which the Company must complete its Initial Business Combination from July 18, 2023, to January 18, 2024. In connection with the vote to approve the Extension Proposal, the holder of one Class A ordinary share of the Company exercised their right to redeem their share for a total redemption amount of $11.

Following the closing of the IPO, $146,625,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Warrants, including the amounts generated from the exercise of the underwriters’ over-allotment option, was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of an Initial Business Combination and (ii) the distribution of the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating an Initial Business Combination. There is no assurance that the Company will be able to complete an Initial Business Combination successfully. The Company must complete one or more Initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account at the time of the agreement to enter into the Initial Business Combination. However, the Company will only complete an Initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect an Initial Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an Initial Business Combination either (i) in connection with a shareholder meeting called to approve the Initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of an Initial Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights with respect to the Company’s warrants.

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Initial Business Combination and in connection with certain amendments to the Articles. In accordance with the rules of the SEC and its guidance on redeemable equity instruments, which has been codified in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A ordinary shares is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001 in connection with approval of an Initial Business Combination, the Public Shares are redeemable and are classified as such on the balance sheet until such date that a redemption event takes place.

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Initial Business Combination. If the Company seeks shareholder approval of the Initial Business Combination, the Company will proceed with an Initial Business Combination if a majority of the shares voted are voted in favor of the Initial Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Articles conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing an Initial Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with an Initial Business Combination, Rose Hill Sponsor LLC (the “Sponsor”) has agreed to vote its Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of approving an Initial Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, the Articles provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the IPO, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Articles that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete an Initial Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete an Initial Business Combination during the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company’s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

On January 24, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with certain requirements of the Nasdaq Listing Rules set forth in (i) 5450(b)(2)(B), requiring a minimum of 1,100,000 Publicly Held Shares, (ii) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market Value of Listed Securities, (iii) Listing Rule 5450(b)(2)(C), requiring a minimum of $15 million in Market Value of Publicly Held Shares and (iv) Listing Rule 5450(a)(2), requiring a minimum of 400 Total Holders (collectively, the “Nasdaq Listing Rules”).

On March 24, 2023, Nasdaq granted the Company an extension until July 24, 2023, by which time the Company must file with the SEC and Nasdaq a public document showing compliance with the Nasdaq Listing Rules. If the Company is unable to regain compliance with the Nasdaq Listing Rules by July 24, 2023, it may be subject to delisting procedures as set forth in the Nasdaq continued listing rules.

On July 26, 2023, the Company received a delisting determination letter (the “Determination Letter”) from the Staff notifying the Company that (i) it had not regained compliance with Nasdaq Listing Rule 5550(a)(4) requiring a minimum of 500,000 publicly held shares and (ii) the Company’s Class A ordinary shares, warrants and units would be subject to delisting from The Nasdaq Capital Market. The Determination Letter further noted that, unless the Company requests an appeal of the Staff’s determination with the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s Class A ordinary shares, warrants and units on The Nasdaq Capital Market would be suspended at the opening of business on August 4, 2023, and a Form 25-NSE would be filed with the SEC removing the Company’s securities from listing and registration on The Nasdaq Capital Market.

With respect to the Determination Letter, on August 1, 2023, the Company requested a hearing before the Panel to appeal the Staff’s determination. The hearing before the Panel is expected to occur on October 5, 2023. The hearing request will stay the suspension and delisting of the Company’s securities pending a decision by the Panel. The Panel may, in its discretion, grant the Company an additional compliance period to regain compliance and maintain its Nasdaq listing; however, there can be no assurance that the Panel will grant such additional time.

Conversion of Class B Ordinary Shares held by the Sponsor

On February 28, 2023, the Sponsor converted 4,000,000 of its Class B ordinary shares to Class A ordinary shares on a 1:1 basis as part of the Company’s plan to regain compliance with the Nasdaq Listing Rules. The Sponsor’s converted Class A ordinary shares are not subject to redemptions and have no rights to funds in the Trust Account.

Founder Shares

Founder Shares refers to the 5,031,250 Class B ordinary shares acquired by the Sponsor prior to the IPO and following the conversion of the Sponsor’s Class B ordinary shares on February 28, 2023, consists of 1,031,250 Class B ordinary shares and 4,000,000 non-redeemable Class A ordinary shares held by the Sponsor.

The 1,031,250 Class B ordinary shares held by the Sponsor will automatically convert into Class A ordinary shares at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment, at any time.

The Initial Shareholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property.

The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares (including the Class A ordinary shares held by the Sponsor) if the Company fails to complete an Initial Business Combination during the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete an Initial Business Combination during the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 4) held in the Trust Account in the event the Company does not complete an Initial Business Combination during the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Going Concern and Liquidity

As of June 30, 2023, the Company had $3,577 in its operating bank accounts, $2,917,376 in securities held in the Trust Account to be used for an Initial Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $1,167,662.

Until the consummation of an Initial Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Initial Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing.

If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed financial statements. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Business Combination with Prize

Business Combination Agreement

On October 20, 2022, the Company entered into a Business Combination Agreement with Inversiones e Inmobilaria GHC Ltda, a limited liability company organized under the laws of Chile (“Prize”) and, for certain limited purposes, Alejandro García Huidobro Empresario Individual (“AGH”) (as amended on July 17, 2023 and as it may be further amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), pursuant to which, and subject to the terms and conditions set forth therein, prior to the consummation of the Business Combination (as defined below), (i) Prize caused to be incorporated under the laws of the Cayman Islands, (a) an exempted company with limited liability to serve as “PubCo” for all purposes under the Business Combination Agreement and (b) an exempted company with limited liability to serve as “Merger Sub” for all purposes under the Business Combination Agreement, (ii) Prize and AGH caused to be incorporated under the laws of Chile, a simplified stock corporation that will serve as “HoldCo” for all purposes under the Business Combination Agreement, in each case, as a direct wholly owned subsidiary of Prize and (iii) Prize and AGH will consummate a pre-closing restructuring pursuant to which, among other things, all subsidiaries of Prize will become direct or indirect subsidiaries of HoldCo, HoldCo will become a wholly owned subsidiary of Merger Sub, and Merger Sub will become a wholly owned subsidiary of Prize (collectively, the “Pre-Closing Restructuring”).

Following the Pre-Closing Restructuring, at the closing of the Business Combination, (i) the Company will be merged with and into PubCo with PubCo continuing as the surviving entity (the “First Merger”) and (ii) subsequent to the First Merger, Merger Sub will be merged with and into PubCo with PubCo continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers”) (such transactions and those otherwise contemplated by the Business Combination Agreement, collectively, the “Business Combination”).

The terms of the Business Combination Agreement, which contains customary representations and warranties, covenants, closing conditions and other terms relating to the Business Combination, are summarized below. Capitalized terms used in this Quarterly Report for the quarter ended June 30, 2023 (“Quarterly Report”) but not otherwise defined herein have the meanings given to them in the Business Combination Agreement, which is included as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2022.

Consideration

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the First Merger, (i) each Rose Hill ordinary share that is issued and outstanding immediately prior to the First Merger will be converted into one validly issued, fully paid and non-assessable PubCo ordinary share, and (ii) all outstanding warrants to purchase ordinary shares of Rose Hill will be converted into warrants to purchase the same number of PubCo ordinary shares and all rights with respect to Rose Hill ordinary shares under such Rose Hill warrants will be converted into rights with respect to the applicable PubCo ordinary shares.

In accordance with the terms and subject to the conditions of the Business Combination Agreement, by virtue of the Second Merger, each Merger Sub ordinary share that is issued and outstanding immediately prior to the Second Merger will be converted into a number of PubCo ordinary shares equal to the quotient of (i) the Equity Value, divided by (ii) the number of Merger Sub ordinary shares that are issued and outstanding immediately prior to the Second Merger, divided by (iii) $10.00. The “Equity Value” under the Business Combination Agreement is an amount equal to (i) $328,000,000, minus (ii) the lesser of (a) the aggregate amount of transaction expenses (the “Specified Transaction Expenses”) of Prize and the Company (other than those expenses incurred in respect of obtaining an equity line of credit or similar financing arrangement to be in place and available to PubCo as of the closing of the Business Combination (“Closing”)) and (b) $10,000,000.

In the event that the Specified Transaction Expenses exceed $10,000,000, then the number of PubCo ordinary shares otherwise issuable to Rose Hill Sponsor LLC (the “Sponsor”) under the Business Combination Agreement will be decreased by a number of shares equal to the amount of such excess divided by $10.00.

On July 17, 2023, Rose Hill, Prize and AGH, entered into Amendment No. 1 to Business Combination Agreement (the “Amendment”), pursuant to which the parties amended the Business Combination Agreement to (i) clarify the amount of shares to be issued by Merger Sub to Prize in connection with the Pre-Closing Restructuring (ii) permit Prize and AGH to solicit, initiate, enter into or continue discussions, negotiations or transactions with, or encourage or respond to any inquiries or proposals by, or provide any information to, any Person, concerning any merger, consolidation, sale of ownership interests and/or substantial portion of the assets, recapitalization or similar transaction of, by or involving Prize, HoldCo, PubCo or Merger Sub and terminate the BCA to enter into a definitive agreement with respect to any such transaction, in each case, until such time as Rose Hill, Prize and applicable investors agree in writing to the key economic terms of subscription agreements with respect to PIPE investments that, if consummated, would result in the receipt of proceeds of at least $50.0 million in the aggregate to PubCo in connection with the consummation of the Closing, and (iii) extend the date by which either Rose Hill, Prize or AGH can terminate the Business Combination Agreement, if the transactions contemplated thereby have not been consummated by such date, from July 18, 2023 to October 18, 2023.

Additionally, Prize has agreed to pay certain operating costs of the Company. For the three and six months ended June 30, 2023, Prize has reimbursed the Company $35,000 and $105,000, respectively, in operating costs. The Company accounts for these funds as contra-expenses in the statements of operations.

Earn-Out Shares

If, at any time following the Closing, the daily volume-weighted average price (“VWAP”) of PubCo ordinary shares is greater than or equal to (a) $18.00, (b) $22.00, (c) $26.00, or (d) $30.00 in each case, over any thirty (30) days on which the PubCo ordinary shares are tradeable on Nasdaq (“Trading Days”) within any consecutive forty-five (45) Trading Day period then PubCo will issue 2,948,800 PubCo ordinary shares to Prize (“Earn-Out Shares”) after the occurrence of each such consecutive forty-five (45) Trading Day period. For the avoidance of doubt, Prize may be entitled to receive a maximum of 11,795,200 Earn-Out Shares in the aggregate in respect of the occurrence of all four Earn-Out Events.

Registration Rights and Lock-up Agreement

In connection with the Closing of the Business Combination Agreement, PubCo, the Sponsor, Prize and certain other parties thereto will enter into a registration rights and lock-up agreement (the “Registration Rights and Lock-Up Agreement”), which, among other things, (i) effective as of the Closing, terminates and replaces the current registration rights agreement, dated as of October 13, 2021, by and among Rose Hill, the Sponsor and the other parties thereto, (ii) provides that PubCo will be obligated to file a registration statement to register the resale of certain PubCo ordinary shares held by Sponsor, Prize and certain other parties thereto, at the consummation of the Business Combination, (iii) provides certain parties thereto including Prize, certain demand and piggyback registration rights, and (iv) provides for certain restrictions on transfer relating to PubCo ordinary shares and warrants to purchase PubCo ordinary shares held by Sponsor, Prize and certain parties thereto.

Company Support Agreement

In connection with the execution of the Business Combination Agreement, Rose Hill, Prize and AGH have entered into a company support agreement (the “Company Support Agreement”) pursuant to which, among other things, AGH has agreed to (a) vote his Merger Sub ordinary shares in favor of the approval and adoption of the Business Combination Agreement and the Business Combination and (b) certain transfer restrictions with respect to his Merger Sub ordinary shares and shares of Prize.

Sponsor Support Agreement

In connection with the execution of the Business Combination Agreement, the Sponsor entered into a sponsor support agreement (the “Sponsor Support Agreement”) pursuant to which the Sponsor has agreed, among other things, to (i) certain restrictions on transfer relating to its ordinary shares of Rose Hill prior to the Closing as set forth therein, (ii) not redeem any of its shares of Rose Hill in connection with the vote to approve the Business Combination or any proposal to extend the date by which Rose Hill must complete an Initial Business Combination, (iii) vote in favor of the Mergers and the other transactions and against any alternative transaction, (iv) waive certain anti-dilution provisions contained in Rose Hill’s Articles in connection with the Mergers and (v) subject a certain number of its Class B ordinary shares of Rose Hill to vesting.

Sponsor Support Agreement Amendment

On July 31, 2023, Rose Hill, the Sponsor, Prize and Prize SuperFoods (“PubCo”), entered into Amendment No. 1 to the Sponsor Support Agreement (the “Amendment”), pursuant to which the parties amended the Sponsor Support Agreement to reflect the parties mutual agreement at the time the Business Combination Agreement, dated as of October 19, 2022, by and among Rose Hill, GHC and, for certain limited purposes, Alejandro García-Huidobro Empresario, an individual (the “Business Combination Agreement”), was executed that the Sponsor will forfeit 3,631,250 Rose Hill ordinary shares immediately prior to the transactions contemplated by the Business Combination Agreement such that the Sponsor will own 1,400,000 Rose Hill ordinary shares immediately following the forfeiture, 700,000 of which are subject to vesting conditions, as described in the Sponsor Support Agreement.

Standby Equity Purchase Agreement

In connection with the execution of the Business Combination Agreement and for purposes of obtaining equity financing on behalf of PubCo at Closing, Prize entered into a standby equity purchase agreement with a financial investor and affiliate of Yorkville Advisors (the “Investor”), pursuant to which, among other things, at the Closing, PubCo will have the right (but not the obligation) to sell to the Investor, and the Investor will purchase from PubCo, up to $150,000,000 of PubCo ordinary shares at a purchase price of 97% of the Market Price (as defined therein) of the PubCo ordinary shares, subject to the terms and conditions set forth therein.

Risks and Uncertainties

The credit and financial markets have experienced extreme volatility and disruptions due in part to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the statement of financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, for the year ended December 31, 2022, as filed with the SEC on March 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of June 30, 2023, is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2023, or for any future interim periods.

Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $3,577 and $96,119 of cash and no cash equivalents as of June 30, 2023 and December 31, 2022, respectively.

Investments Held in Trust Account

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held U.S. Money Market Funds primarily invested in U.S. Treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At June 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

FASB ASC 740, “Income Taxes”, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023, or December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. At June 30, 2023 and December 31, 2022, 256,893 and 14,375,000 shares of Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. At June 30, 2023 and December 31, 2022, 4,000,000 and 0 shares of Class A ordinary shares not subject to possible redemption is presented as equity as a component of shareholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Net Income per ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares subject to possible redemption or Public Shares and the Founder Shares which include the Class B ordinary shares and the Class A ordinary shares held by the Sponsor, not subject to possible redemption. Earnings and losses are shared pro rata between the two classes of shares. Public Warrants and Private Placement Warrants to purchase 13,287,500 ordinary shares at $11.50 per share were issued on October 18, 2021. At June 30, 2023 and 2022, no Public Warrants or Private Placement Warrants have been exercised. The 13,287,500 potential shares of Class A ordinary shares for outstanding Public Warrants and Private Placement Warrants to purchase the Company’s shares were excluded from diluted earnings per share for the three and six months ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary shares is the same as basic net income per ordinary shares for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of share.

For the three months ended June 30, 2023:

Net loss	$	(409,427	)
Less: Accretion of temporary equity to redemption value		(34,385	)
Net loss excluding accretion of temporary equity to redemption	$	(443,812	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Ownership percentage		5	%		95	%
Total loss allocated	$	(19,890	)	$	(389,537	)	$	(409,427	)
Less: Accretion allocated based on ownership percentage		(1,670	)		(32,715	)		(34,385	)
Plus: Accretion applicable to Class A redeemable shares		34,385			—			34,385
Total income (loss) by class	$	12,825		$	(422,252	)	$	(409,427	)
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Income (loss) per share	$	0.05		$	(0.08	)

For the three months ended June 30, 2022:

Net income	$	128,347
Less: Accretion of temporary equity to redemption value		(198,121	)
Net income excluding accretion of temporary equity to redemption	$	(69,774	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	95,072		$	33,275		$	128,347
Less: Accretion allocated based on ownership percentage		(146,756	)		(51,365	)		(198,121	)
Plus: Accretion applicable to Class A redeemable shares		198,121			—			198,121
Total income by class	$	146,437		$	(18,090	)	$	128,347
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.01		$	—

For the six months ended June 30, 2023:

Net income	$	531,910
Less: Accretion of temporary equity to redemption value		(434,312	)
Net income excluding accretion of temporary equity to redemption	$	97,598

	Class A shares subject to redemption			Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Ownership percentage		17	%		83	%
Total income allocated	$	90,891		$	441,019		$	531,910
Less: Accretion allocated based on ownership percentage		(74,213	)		(360,099	)		(434,312	)
Plus: Accretion applicable to Class A redeemable shares		434,312			—			434,312
Total income by class	$	450,990		$	80,920		$	531,910
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Income per share	$	0.43		$	0.02

For the six months ended June 30, 2022:

Net income	$	2,809,665
Less: Accretion of temporary equity to redemption value		(212,901	)
Net income excluding accretion of temporary equity to redemption	$	2,596,764

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	2,081,233		$	728,432		$	2,809,665
Less: Accretion allocated based on ownership percentage		(157,704	)		(55,197	)		(212,901	)
Plus: Accretion applicable to Class A redeemable shares		212,901			—			212,901
Total income by class	$	2,136,430		$	673,235		$	2,809,665
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.15		$	0.13

Accounting for Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own ordinary shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants issued pursuant to the warrant agreement qualify for liability accounting treatment.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2023

Related Party Transactions [Abstract]

Related Party Transactions

Note 3 — Related Party Transactions

Working Capital Loans

In order to finance transaction costs in connection with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an Initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an Initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of an Initial Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Initial Business Combination entity at a price of $1.25 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding.

Support Services

The Company pays for services related to office space a fee of up to $10,000 per month following the consummation of the IPO until the earlier of the consummation of the Initial Business Combination or liquidation. In addition, the Company may make payments of up to $13,000 per month to members of the management team for services rendered to the Company commencing on the date that the Company's securities are first listed on Nasdaq through the earlier of consummation of the Initial Business Combination and our liquidation.

For the three and six months ended June 30, 2023, $2,100 and $3,500, respectively, has been incurred and paid under this agreement. For the three and six months ended June 30, 2022, $39,000 and $78,000, respectively, has been incurred and paid under this agreement.

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 4 — Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement signed on or before the date of the prospectus for the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were entitled to a deferred underwriting commissions of $0.50 per Unit, or $7,187,500 from the closing of the IPO. In association with the redemption of the Company’s Class A ordinary shares on January 12, 2023, the underwriters have agreed to a reduced commission of $1,500,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

The Company treated the $5,687,500 reduction of the deferred underwriting commissions as a reversal of offering costs of the IPO. As such, $270,725 of recovery of offering costs allocated to warrants is reported on the condensed statement of operations under other income and $5,416,775 of recovery of deferred underwriting commissions is reported on the condensed statement of changes in redeemable ordinary shares and shareholders’ deficit under recovery of deferred underwriter commission.

Business Combination Agreement

As disclosed in Note 1, on October 20, 2022, the Company entered into a Business Combination Agreement by and among Prize, Merger Sub, PubCo, HoldCo and, for certain limited purposes, AGH.

Shareholder Approvals

As discussed in Note 1, on January 12, 2023, the Company held the Meeting at which the shareholders approved the Extension Proposal to extend the date by which the Company must complete its Initial Business Combination from January 18, 2023, to July 18, 2023. Additionally, the shareholders approved the Clarification Proposal to acknowledge and clarify that pursuant to the Articles, approval of the Company’s Initial Business Combination requires an ordinary resolution.

In connection with the vote to approve the Extension Proposal and Clarification Proposal, the holders of 14,118,106 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of approximately $146 million.

As discussed in Note 1, on June 29, 2023, the Company’s shareholders approved the proposal to extend the date by which the Company must complete its Initial Business Combination from July 18, 2023, to January 18, 2024. In connection with the vote to approve the Extension Proposal, the holder of one Class A ordinary share of the Company exercised their right to redeem their share for a total redemption amount of $11.

XML

Shareholder's Equity

6 Months Ended

Jun. 30, 2023

Shareholders' Equity [Abstract]

Shareholders' Equity

Note 5 — Shareholders’ Deficit

Preference Shares — The Company is authorized to issue 2,000,000 shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

Ordinary Shares

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were 4,000,000 and -0- shares of Class A ordinary shares issued and outstanding (excluding 256,893 and 14,375,000 shares of Class A ordinary shares subject to possible redemption), respectively.

As discussed in Note 1, on January 24, 2023, the Company received the Notice from the Staff of Nasdaq indicating that the Company was not in compliance with certain requirements of the Nasdaq Listing Rules.  As part of the Company’s plan to regain compliance with the Nasdaq Listing Rules, on February 28, 2023, the Sponsor converted  4,000,000 Class B ordinary shares to Class A ordinary shares on a 1:1 basis. The Sponsor’s converted Class A ordinary shares are not subject to redemptions and have no rights to funds held in the Trust Account.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 1,031,250 and 5,031,250 shares of Class B ordinary shares outstanding, respectively.

Holders of shares of Class A ordinary shares and shares of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders.

The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the Initial Business Combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the IPO plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.

XML

Warrant Liabilities

6 Months Ended

Jun. 30, 2023

Warrant Liabilities [Abstract]

Warrant Liabilities

Note 6 — Warrant Liabilities

Warrants —The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such shares of ordinary shares. Notwithstanding the foregoing, if a registration statement covering the shares of ordinary shares issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of an Initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation.

Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00

Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):

• in whole and not in part;

• at a price of $0.01 per warrant;

• upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the “30-day redemption period”; and

• if, and only if, the last reported sale price (the “closing price”) of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders.

We will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Except as set forth below, none of the private placement warrants will be redeemable by us so long as they are held by our Sponsor, Canto, Cohen or their permitted transferees.

The “fair market value” of our Class A ordinary shares for the above purpose shall mean the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. We will provide our warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the private placement warrants.

No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. Please see the section entitled “Description of Securities — Warrants — Public Shareholders’ Warrants” for additional information.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The Private Warrants are identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Warrants and the shares of ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The exercise price and number of shares of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete an Initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if the Company issues additional shares of ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of an Initial Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an Initial Business Combination on the date of the consummation of an Initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates an Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of ordinary shares or equity-linked securities.

The Company accounts for the Public Warrants and Private Placement Warrants as liabilities in accordance with the guidance contained in ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability.

Additionally, certain adjustments to the settlement amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815 — 40, and thus the Private Placement Warrants are not considered indexed to the Company’s own share and not eligible for an exception from derivative accounting.

The accounting treatment of derivative financial instruments required that the Company record a derivative liability upon issuance of the warrants at the closing of the IPO. Accordingly, the Company classified each warrant as a liability at its fair value. The Public Warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined with the assistance of a professional independent valuation firm. The warrant liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification of the warrants at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2023

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 7 — Fair Value Measurements

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

At June 30, 2023 and December 31, 2022, assets held in the Trust Account were comprised of U.S. Money Market Funds primarily invested in U.S. Treasury obligations.

At June 30, 2023 and December 31, 2022, there were 7,187,500 Public Warrants and 6,100,000 Private Placement Warrants outstanding.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis indicating the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

JUNE 30, 2023:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	2,917,376	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	179,688	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	152,500	$	—

DECEMBER 31, 2022:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	148,742,661	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	718,750	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	610,000	$	—

At June 30, 2023 and December 31, 2022 the fair value of the Public Warrants was based on quoted market prices in an active market. The Company considers the Private Placement Warrants to be economically equivalent to the Public Warrants. As such, the fair value of the Private Placement Warrants is measured by reference to the trading price of the Public Warrants; which is considered a Level 2 fair value measurement.

At June 30, 2023 and December 31, 2022, the Public Warrants and Private Placement Warrants were valued at $0.025 and $0.10, respectively.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2023

Subsequent Events [Abstract]

Subsequent Events

Note 8 - Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based on this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

On July 17, 2023, the Company (“Rose Hill”), Prize and AGH, entered into Amendment No. 1 to Business Combination Agreement (the “Amendment”), pursuant to which the parties amended the Business Combination Agreement to (i) clarify the amount of shares to be issued by Merger Sub to Prize in connection with the Pre-Closing Restructuring, (ii) permit Prize and AGH to solicit, initiate, enter into or continue discussions, negotiations or transactions with, or encourage or respond to any inquiries or proposals by, or provide any information to, any Person, concerning any merger, consolidation, sale of ownership interests and/or substantial portion of the assets, recapitalization or similar transaction of, by or involving Prize, HoldCo, PubCo or Merger Sub and terminate the Business Combination Agreement to enter into a definitive agreement with respect to any such transaction, in each case, until such time as Rose Hill, Prize and applicable investors agree in writing to the key economic terms of subscription agreements with respect to PIPE investments that, if consummated, would result in the receipt of proceeds of at least $50.0 million in the aggregate to PubCo in connection with the Closing, and (iii) extend the date by which either Rose Hill, Prize or AGH can terminate the Business Combination Agreement, if the transactions contemplated thereby have not been consummated by such date, from July 18, 2023 to October 18, 2023.

On July 26, 2023, the Company received a delisting determination letter (the “Determination Letter”) from the Staff notifying the Company that (i) it had not regained compliance with Nasdaq Listing Rule 5550(a)(4) requiring a minimum of 500,000 publicly held shares and (ii) the Company’s Class A ordinary shares, warrants and units are subject to delisting from The Nasdaq Capital Market. The Determination Letter further noted that, unless the Company requests an appeal of the Staff’s determination with the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s Class A ordinary shares, warrants and units on The Nasdaq Capital Market will be suspended at the opening of business on August 4, 2023, and a Form 25-NSE would be filed with the SEC removing the Company’s securities from listing and registration on The Nasdaq Capital Market.

With respect to the Determination Letter, on August 1, 2023, the Company requested a hearing before the Panel to appeal the Staff’s determination. The hearing before the Panel is expected to occur on October 5, 2023. The hearing request will stay the suspension and delisting of the Company’s securities pending a decision by the Panel. The Panel may, in its discretion, grant the Company an additional compliance period to regain compliance and maintain its Nasdaq listing; however, there can be no assurance that the Panel will grant such additional time.

On July 31, 2023, Rose Hill, the Sponsor, Prize and Prize SuperFoods (“PubCo”), entered into Amendment No. 1 to the Sponsor Support Agreement (the “Amendment”), pursuant to which the parties amended the Sponsor Support Agreement to reflect the parties mutual agreement at the time the Business Combination Agreement, dated as of October 19, 2022, by and among Rose Hill, GHC and, for certain limited purposes, Alejandro García-Huidobro Empresario, an individual (the “Business Combination Agreement”), was executed that the Sponsor will forfeit 3,631,250 Rose Hill ordinary shares immediately prior to the transactions contemplated by the Business Combination Agreement such that the Sponsor will own 1,400,000 Rose Hill ordinary shares immediately following the forfeiture, 700,000 of which are subject to vesting conditions, as described in the Sponsor Support Agreement.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the statement of financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, for the year ended December 31, 2022, as filed with the SEC on March 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of June 30, 2023, is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2023, or for any future interim periods.

Use of Estimates

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $3,577 and $96,119 of cash and no cash equivalents as of June 30, 2023 and December 31, 2022, respectively.

Investments Held in Trust Account

Investments Held in Trust Account

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held U.S. Money Market Funds primarily invested in U.S. Treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Financial Instruments

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At June 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

FASB ASC 740, “Income Taxes”, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023, or December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Class A Ordinary Shares Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. At June 30, 2023 and December 31, 2022, 256,893 and 14,375,000 shares of Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. At June 30, 2023 and December 31, 2022, 4,000,000 and 0 shares of Class A ordinary shares not subject to possible redemption is presented as equity as a component of shareholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Net Income per Ordinary Share

Net Income per ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares subject to possible redemption or Public Shares and the Founder Shares which include the Class B ordinary shares and the Class A ordinary shares held by the Sponsor, not subject to possible redemption. Earnings and losses are shared pro rata between the two classes of shares. Public Warrants and Private Placement Warrants to purchase 13,287,500 ordinary shares at $11.50 per share were issued on October 18, 2021. At June 30, 2023 and 2022, no Public Warrants or Private Placement Warrants have been exercised. The 13,287,500 potential shares of Class A ordinary shares for outstanding Public Warrants and Private Placement Warrants to purchase the Company’s shares were excluded from diluted earnings per share for the three and six months ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary shares is the same as basic net income per ordinary shares for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of share.

For the three months ended June 30, 2023:

Net loss	$	(409,427	)
Less: Accretion of temporary equity to redemption value		(34,385	)
Net loss excluding accretion of temporary equity to redemption	$	(443,812	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Ownership percentage		5	%		95	%
Total loss allocated	$	(19,890	)	$	(389,537	)	$	(409,427	)
Less: Accretion allocated based on ownership percentage		(1,670	)		(32,715	)		(34,385	)
Plus: Accretion applicable to Class A redeemable shares		34,385			—			34,385
Total income (loss) by class	$	12,825		$	(422,252	)	$	(409,427	)
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Income (loss) per share	$	0.05		$	(0.08	)

For the three months ended June 30, 2022:

Net income	$	128,347
Less: Accretion of temporary equity to redemption value		(198,121	)
Net income excluding accretion of temporary equity to redemption	$	(69,774	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	95,072		$	33,275		$	128,347
Less: Accretion allocated based on ownership percentage		(146,756	)		(51,365	)		(198,121	)
Plus: Accretion applicable to Class A redeemable shares		198,121			—			198,121
Total income by class	$	146,437		$	(18,090	)	$	128,347
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.01		$	—

For the six months ended June 30, 2023:

Net income	$	531,910
Less: Accretion of temporary equity to redemption value		(434,312	)
Net income excluding accretion of temporary equity to redemption	$	97,598

	Class A shares subject to redemption			Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Ownership percentage		17	%		83	%
Total income allocated	$	90,891		$	441,019		$	531,910
Less: Accretion allocated based on ownership percentage		(74,213	)		(360,099	)		(434,312	)
Plus: Accretion applicable to Class A redeemable shares		434,312			—			434,312
Total income by class	$	450,990		$	80,920		$	531,910
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Income per share	$	0.43		$	0.02

For the six months ended June 30, 2022:

Net income	$	2,809,665
Less: Accretion of temporary equity to redemption value		(212,901	)
Net income excluding accretion of temporary equity to redemption	$	2,596,764

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	2,081,233		$	728,432		$	2,809,665
Less: Accretion allocated based on ownership percentage		(157,704	)		(55,197	)		(212,901	)
Plus: Accretion applicable to Class A redeemable shares		212,901			—			212,901
Total income by class	$	2,136,430		$	673,235		$	2,809,665
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.15		$	0.13

Accounting for Warrants

Accounting for Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own ordinary shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants issued pursuant to the warrant agreement qualify for liability accounting treatment.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Basic and Diluted Net Income Per Ordinary Share

For the three months ended June 30, 2023:

Net loss	$	(409,427	)
Less: Accretion of temporary equity to redemption value		(34,385	)
Net loss excluding accretion of temporary equity to redemption	$	(443,812	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Ownership percentage		5	%		95	%
Total loss allocated	$	(19,890	)	$	(389,537	)	$	(409,427	)
Less: Accretion allocated based on ownership percentage		(1,670	)		(32,715	)		(34,385	)
Plus: Accretion applicable to Class A redeemable shares		34,385			—			34,385
Total income (loss) by class	$	12,825		$	(422,252	)	$	(409,427	)
Weighted Average Shares outstanding		256,894			5,031,250			5,288,144
Income (loss) per share	$	0.05		$	(0.08	)

For the three months ended June 30, 2022:

Net income	$	128,347
Less: Accretion of temporary equity to redemption value		(198,121	)
Net income excluding accretion of temporary equity to redemption	$	(69,774	)

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	95,072		$	33,275		$	128,347
Less: Accretion allocated based on ownership percentage		(146,756	)		(51,365	)		(198,121	)
Plus: Accretion applicable to Class A redeemable shares		198,121			—			198,121
Total income by class	$	146,437		$	(18,090	)	$	128,347
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.01		$	—

For the six months ended June 30, 2023:

Net income	$	531,910
Less: Accretion of temporary equity to redemption value		(434,312	)
Net income excluding accretion of temporary equity to redemption	$	97,598

	Class A shares subject to redemption			Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Ownership percentage		17	%		83	%
Total income allocated	$	90,891		$	441,019		$	531,910
Less: Accretion allocated based on ownership percentage		(74,213	)		(360,099	)		(434,312	)
Plus: Accretion applicable to Class A redeemable shares		434,312			—			434,312
Total income by class	$	450,990		$	80,920		$	531,910
Weighted Average Shares outstanding		1,036,900			5,031,250			6,068,150
Income per share	$	0.43		$	0.02

For the six months ended June 30, 2022:

Net income	$	2,809,665
Less: Accretion of temporary equity to redemption value		(212,901	)
Net income excluding accretion of temporary equity to redemption	$	2,596,764

	Class A shares subject to redemption			Class A and Class B shares not subject to redemption			Total
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Ownership percentage		74	%		26	%
Total income allocated	$	2,081,233		$	728,432		$	2,809,665
Less: Accretion allocated based on ownership percentage		(157,704	)		(55,197	)		(212,901	)
Plus: Accretion applicable to Class A redeemable shares		212,901			—			212,901
Total income by class	$	2,136,430		$	673,235		$	2,809,665
Weighted Average Shares outstanding		14,375,000			5,031,250			19,406,250
Income per share	$	0.15		$	0.13

XML

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2023

Fair Value Measurements [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis indicating the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

JUNE 30, 2023:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	2,917,376	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	179,688	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	152,500	$	—

DECEMBER 31, 2022:

	Level 1		Level 2		Level 3
Assets:
U.S. Money Market Funds	$	148,742,661	$	—	$	—
Liabilities:
Warrant Liability - Public Warrants	$	718,750	$	—	$	—
Warrant Liability - Private Warrants	$	—	$	610,000	$	—

XML

Description of Organization and Business Operations, Summary (Details)							3 Months Ended		6 Months Ended
	Jul. 26, 2023 shares	Jun. 29, 2023 USD ($)	Feb. 28, 2023 shares	Jan. 24, 2023 USD ($) Investors shares	Jan. 12, 2023 USD ($) $ / shares shares	Oct. 18, 2021 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) shares	Jun. 30, 2023 USD ($) Business $ / shares shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 shares
Description of Organization and Business Operations [Abstract]
Class A shares redeemed					14,118,106
Redemption price, per share | $ / shares					$ 10.36		$ 10.36		$ 10.36
Redemption amount | $		$ 11			$ 146,000,000			$ 0
Assets Held-in-trust | $					$ 2,800,000
Payments to acquire marketable securities | $						$ 146,625,000			$ 434,312	$ 0
Cash deposited in trust account per unit (in dollars per share) | $ / shares						$ 10.2
Term of restricted investments									180 days
Net tangible assets threshold for redeeming Public Shares | $							$ 5,000,001		$ 5,000,001
Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period									100.00%
Period to redeem public shares if business combination is not completed within initial combination period									10 days
Number of shares held for public (in shares)				1,100,000
Minimum amount required for market value of listed securities | $				$ 50,000,000
Minimum amount required for market value of publicly held shares | $				$ 15,000,000
Minimum number of total holders | Investors				400
Common stock, shares outstanding (in shares)							4,000,000	0	4,000,000
Subsequent Event [Member]
Description of Organization and Business Operations [Abstract]
Number of shares held for public (in shares)	500,000
Minimum [Member]
Description of Organization and Business Operations [Abstract]
Number of operating businesses included in initial business combination | Business									1
Fair market value as percentage of net assets held in trust account included in initial business combination									80.00%
Post-transaction ownership percentage of the target business									50.00%
Maximum [Member]
Description of Organization and Business Operations [Abstract]
Percentage of public shares that can be redeemed without prior consent									15.00%
Interest from trust account that can be held to pay dissolution expenses | $							$ 100,000		$ 100,000
Sponsor [Member]
Description of Organization and Business Operations [Abstract]
Holding period for transfer, assignment or sale of founder shares							1 year
Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Abstract]
Redemption amount | $		$ 11
Common stock, shares outstanding (in shares)							4,000,000		4,000,000		0
Threshold trading days							20 days
Threshold consecutive trading days							30 days
Class A Ordinary Shares [Member] | Minimum [Member]
Description of Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares							$ 12		$ 12
Period after initial business combination							150 days
Class A Ordinary Shares [Member] | Sponsor [Member]
Description of Organization and Business Operations [Abstract]
Conversion of class B ordinary shares to Class A ordinary shares (in shares)			4,000,000
Common stock, shares outstanding (in shares)			4,000,000
Convertible Common Stock B [Member]
Description of Organization and Business Operations [Abstract]
Conversion of class B ordinary shares to Class A ordinary shares (in shares)									4,000,000
Convertible Common Stock B [Member] | Sponsor [Member]
Description of Organization and Business Operations [Abstract]
Stock conversion (in shares)			1
Class B Ordinary Shares [Member]
Description of Organization and Business Operations [Abstract]
Common stock, shares outstanding (in shares)							1,031,250		1,031,250		5,031,250
Class B Ordinary Shares [Member] | Sponsor [Member]
Description of Organization and Business Operations [Abstract]
Common stock, shares outstanding (in shares)			1,031,250								5,031,250
IPO [Member]
Description of Organization and Business Operations [Abstract]
Units issued (in shares)						12,500,000
Shares price (in dollars per share) | $ / shares						$ 10
Gross proceeds from initial public offering | $						$ 125,000,000
IPO [Member] | Private Placement Warrants [Member]
Description of Organization and Business Operations [Abstract]
Shares price (in dollars per share) | $ / shares						$ 11.5

XML

Description of Organization and Business Operations, Going Concern and Liquidity (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Going Concern and Liquidity [Abstract]
Cash at bank	$ 3,577	$ 96,119
Investments held in Trust Account	2,917,376	$ 148,742,661
Working capital	$ 1,167,662

XML

Description of Organization and Business Operations, Business Combination with Prize (Details)			3 Months Ended	6 Months Ended
	Jul. 17, 2023 USD ($)	Oct. 20, 2022 USD ($) Event $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jul. 31, 2023 shares
Subsequent Event [Member]
Business Combination Agreement [Abstract]
Proceeds from issuance of common stock to Sponsor	$ 50,000,000
Sponsor [Member] | Subsequent Event [Member]
Business Combination Agreement [Abstract]
Proceeds from issuance of common stock to Sponsor	$ 50,000,000
Shares subject to forfeiture (in shares) | shares					3,631,250
Common stock, shares outstanding (in shares) | shares					1,400,000
Common shares subject to vesting conditions (in shares) | shares					700,000
Consideration [Member]
Business Combination Agreement [Abstract]
Reimbursed in operating cost			$ 35,000	$ 105,000
Consideration [Member] | Second Merger [Member]
Business Combination Agreement [Abstract]
Divided price (in dollars per share) | $ / shares		$ 10
Equity value under business combination agreement amount		$ 328,000,000
Specified transaction expenses		$ 10,000,000
Earn-Out Shares [Member]
Business Combination Agreement [Abstract]
Trading day period to volume weighted average price				30 days
Consecutive trading days				45 days
Ordinary shares, shares issued (in shares) | shares		2,948,800
Maximum shares received for prize (in shares) | shares		11,795,200
Number of earn out events | Event		4
Earn-Out Shares [Member] | Case 1 [Member]
Business Combination Agreement [Abstract]
Daily volume-weighted average price (in dollars per share) | $ / shares		$ 18
Earn-Out Shares [Member] | Case 2 [Member]
Business Combination Agreement [Abstract]
Daily volume-weighted average price (in dollars per share) | $ / shares		22
Earn-Out Shares [Member] | Case 3 [Member]
Business Combination Agreement [Abstract]
Daily volume-weighted average price (in dollars per share) | $ / shares		26
Earn-Out Shares [Member] | Case 4 [Member]
Business Combination Agreement [Abstract]
Daily volume-weighted average price (in dollars per share) | $ / shares		$ 30
Standby Equity Purchase Agreement [Member]
Business Combination Agreement [Abstract]
Market price		97.00%
Standby Equity Purchase Agreement [Member] | Maximum [Member]
Business Combination Agreement [Abstract]
Purchase price		$ 150,000,000

XML

Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash	$ 3,577	$ 96,119
Cash equivalents	$ 0	$ 0

XML

Summary of Significant Accounting Policies, Income Taxes (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0	$ 0

XML

Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) - shares	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Common Stock Subject To Possible Redemption [Abstract]
Class A ordinary shares not subject to possible redemption (in shares)	4,000,000	0
Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)	256,893		14,375,000
Class A ordinary shares not subject to possible redemption (in shares)	4,000,000		0

XML

Summary of Significant Accounting Policies, Net Income per ordinary Share (Details)		3 Months Ended				6 Months Ended
	Oct. 18, 2021 $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($)	Jun. 30, 2023 USD ($) Class $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares
Net Income per Ordinary Share [Abstract]
Number of share classes reported | Class						2
Net income (loss)		$ (409,427)	$ 941,337	$ 128,347	$ 2,681,318	$ 531,910	$ 2,809,665
Less: Accretion of temporary equity to redemption value		(34,385)		(198,121)		(434,312)	(212,901)
Net loss excluding accretion of temporary equity to redemption		(443,812)		(69,774)		97,598	2,596,764
Total income allocated		(409,427)		128,347		531,910	2,809,665
Less: Accretion allocated based on ownership percentage		(34,385)		(198,121)		(434,312)	(212,901)
Plus: Accretion applicable to Class A redeemable shares		34,385		198,121		434,312	212,901
Total income (loss) by class		$ (409,427)		$ 128,347		$ 531,910	$ 2,809,665
Weighted average shares outstanding basic (in shares) | shares		5,288,144		19,406,250		6,068,150	19,406,250
Weighted average shares outstanding diluted (in shares) | shares		5,288,144		19,406,250			19,406,250
Public Warrants [Member]
Net Income per Ordinary Share [Abstract]
Number of shares issued upon exercise of warrant (in shares) | shares				0			0
Private Placement Warrants [Member]
Net Income per Ordinary Share [Abstract]
Number of shares issued upon exercise of warrant (in shares) | shares				0			0
Class A Ordinary Shares [Member]
Net Income per Ordinary Share [Abstract]
Weighted average shares outstanding basic (in shares) | shares							5,031,250
Class B Ordinary Shares [Member]
Net Income per Ordinary Share [Abstract]
Less: Accretion of temporary equity to redemption value		$ 0		$ 0		$ 0	$ 0
Ownership percentage		95.00%		26.00%		83.00%	26.00%
Total income allocated		$ (389,537)		$ 33,275		$ 441,019	$ 728,432
Less: Accretion allocated based on ownership percentage		(32,715)		(51,365)		(360,099)	(55,197)
Plus: Accretion applicable to Class A redeemable shares		0		0		0	0
Total income (loss) by class		$ (422,252)		$ (18,090)		$ 80,920	$ 673,235
Weighted average shares outstanding basic (in shares) | shares		5,031,250		5,031,250		5,031,250	5,031,250
Weighted average shares outstanding diluted (in shares) | shares		5,031,250		5,031,250			5,031,250
Income (loss) per share, basic (in dollars per share) | $ / shares		$ (0.08)		$ 0		$ 0.02	$ 0.13
Income (loss) per share, diluted (in dollars per share) | $ / shares		$ (0.08)		$ 0		$ 0.02	$ 0.13
Common Class A and B [Member]
Net Income per Ordinary Share [Abstract]
Less: Accretion of temporary equity to redemption value		$ 0		$ 0			$ 0
Ownership percentage		95.00%		26.00%			26.00%
Total income allocated		$ (389,537)		$ 33,275			$ 728,432
Less: Accretion allocated based on ownership percentage		(32,715)		(51,365)			(55,197)
Plus: Accretion applicable to Class A redeemable shares		0		0			0
Total income (loss) by class		$ (422,252)		$ (18,090)			$ 673,235
Weighted average shares outstanding basic (in shares) | shares		5,031,250		5,031,250		5,031,250	5,031,250
Weighted average shares outstanding diluted (in shares) | shares		5,031,250		5,031,250		5,031,250	5,031,250
Income (loss) per share, basic (in dollars per share) | $ / shares		$ (0.08)		$ 0		$ 0.02	$ 0.13
Income (loss) per share, diluted (in dollars per share) | $ / shares		$ (0.08)		$ 0		$ 0.02	$ 0.13
Shares Subject to Possible Redemption [Member]
Net Income per Ordinary Share [Abstract]
Weighted average shares outstanding basic (in shares) | shares		256,894
Shares Subject to Possible Redemption [Member] | Class A Ordinary Shares [Member]
Net Income per Ordinary Share [Abstract]
Less: Accretion of temporary equity to redemption value		$ (34,385)		$ (198,121)		$ (434,312)	$ (212,901)
Ownership percentage		5.00%		74.00%		17.00%	74.00%
Total income allocated		$ (19,890)		$ 95,072		$ 90,891	$ 2,081,233
Less: Accretion allocated based on ownership percentage		(1,670)		(146,756)		(74,213)	(157,704)
Plus: Accretion applicable to Class A redeemable shares		34,385		198,121		434,312	212,901
Total income (loss) by class		$ 12,825		$ 146,437		$ 450,990	$ 2,136,430
Weighted average shares outstanding basic (in shares) | shares		256,894		14,375,000		1,036,900	14,375,000
Weighted average shares outstanding diluted (in shares) | shares		256,894		14,375,000			14,375,000
Income (loss) per share, basic (in dollars per share) | $ / shares		$ 0.05		$ 0.01		$ 0.43	$ 0.15
Income (loss) per share, diluted (in dollars per share) | $ / shares		$ 0.05		$ 0.01		$ 0.43	$ 0.15
IPO [Member]
Net Income per Ordinary Share [Abstract]
Share price (in dollars per share) | $ / shares	$ 10
IPO [Member] | Public Warrants [Member]
Net Income per Ordinary Share [Abstract]
Warrants issued (in shares) | shares	13,287,500
Share price (in dollars per share) | $ / shares	$ 11.5
IPO [Member] | Private Placement Warrants [Member]
Net Income per Ordinary Share [Abstract]
Warrants issued (in shares) | shares	13,287,500
Share price (in dollars per share) | $ / shares	$ 11.5

XML

Related Party Transactions, Related Party Loans (Details) - Working Capital Loans [Member] - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Related Party Loans [Abstract]
Borrowing outstanding	$ 0	$ 0
Notes Payable, Related Party, Type [Extensible Enumeration]	Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]	Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]
Related Party Loans [Abstract]
Conversion price (in dollars per share)	$ 1.25
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Maximum [Member]
Related Party Loans [Abstract]
Loans that can be converted into Warrants at lenders' discretion	$ 1,500,000

XML

Related Party Transactions, Support Services (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Sponsor [Member] | Administrative Services Agreement [Member]
Support Services [Abstract]
Monthly expenses			$ 10,000
Accrued expenses	$ 2,100	$ 39,000	3,500	$ 78,000
Management Team [Member]
Support Services [Abstract]
Monthly expenses			$ 13,000

XML

Commitments and Contingencies (Details) - USD ($)				3 Months Ended			6 Months Ended
	Jun. 29, 2023	Jan. 12, 2023	Oct. 18, 2021	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Underwriting Agreement [Abstract]
Deferred underwriting commissions per Unit (in dollars per share)			$ 0.5
Deferred underwriting commissions			$ 7,187,500
Underwriters reduced commission		$ 1,500,000		$ 1,500,000			$ 1,500,000		$ 7,187,500
Recovery of offering costs allocated to warrants			270,725	$ 0		$ 0	$ (270,725)	$ 0
Amount of underwriter commissions recovered			$ 5,416,775		$ 5,416,775
Number of shares exercised right to redeem shares (in shares)		14,118,106
Ordinary shares redemption price (in dollars per share)		$ 10.36		$ 10.36			$ 10.36
Redemption amount	$ 11	$ 146,000,000			$ 0
IPO [Member]
Underwriting Agreement [Abstract]
Deferred underwriting commissions				$ 5,687,500			$ 5,687,500
Class A Ordinary Shares [Member]
Underwriting Agreement [Abstract]
Redemption amount	$ 11

XML

Shareholder's Equity, Preference Shares (Details) - shares	Jun. 30, 2023	Dec. 31, 2022
Shareholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	2,000,000	2,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Preferred Stock [Member]
Shareholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	2,000,000	2,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0

XML

Shareholder's Equity, Ordinary Shares (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares	Mar. 31, 2023 shares	Dec. 31, 2022 $ / shares shares
Stockholders' Equity Note [Abstract]
Common stock, shares outstanding (in shares)	4,000,000	0
Stock conversion basis of Class B to Class A ordinary shares at time of initial Business Combination	1
As-converted percentage for Class A ordinary shares after conversion of Class B shares	20.00%
Class A Ordinary Shares [Member]
Stockholders' Equity Note [Abstract]
Common stock, shares authorized (in shares)	200,000,000		200,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001
Ordinary shares, shares issued (in shares)	4,000,000		0
Common stock, shares outstanding (in shares)	4,000,000		0
Ordinary shares subject to possible redemption (in shares)	256,893		14,375,000
Convertible Common Stock B [Member]
Stockholders' Equity Note [Abstract]
Share Conversion ( in shares)	4,000,000
Class B Ordinary Shares [Member]
Stockholders' Equity Note [Abstract]
Common stock, shares authorized (in shares)	20,000,000		20,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001
Ordinary shares, shares issued (in shares)	1,031,250		5,031,250
Common stock, shares outstanding (in shares)	1,031,250		5,031,250

XML

Warrant Liabilities (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2023 $ / shares	Jun. 30, 2023 $ / shares
Class A Ordinary Shares [Member]
Warrants Liability [Abstract]
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Class A Ordinary Shares [Member] | Minimum [Member]
Warrants Liability [Abstract]
Share price (in dollars per share)	$ 12	$ 12
Public Warrants [Member]
Warrants Liability [Abstract]
Period to exercise warrants after business combination		30 days
Expiration period of warrants	5 years	5 years
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member]
Warrants Liability [Abstract]
Warrant redemption price (in dollars per share)	$ 0.01	$ 0.01
Redemption period		30 days
Threshold trading days		20 days
Threshold consecutive trading days		30 days
Threshold period before sending notice period		3 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Minimum [Member]
Warrants Liability [Abstract]
Notice period to redeem warrants		30 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Ordinary Shares [Member]
Warrants Liability [Abstract]
Trading day period to calculate volume weighted average trading price following notice of redemption		10 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Ordinary Shares [Member] | Minimum [Member]
Warrants Liability [Abstract]
Share price (in dollars per share)	18	$ 18
Additional Issue of Common Stock or Equity-Linked Securities [Member]
Warrants Liability [Abstract]
Percentage multiplier		115.00%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Minimum [Member]
Warrants Liability [Abstract]
Aggregate gross proceeds from issuance as a percentage of total equity proceeds		60.00%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Ordinary Shares [Member]
Warrants Liability [Abstract]
Trading day period to calculate volume weighted average trading price		20 days
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Ordinary Shares [Member] | Maximum [Member]
Warrants Liability [Abstract]
Share price (in dollars per share)	$ 9.2	$ 9.2

XML

Fair Value Measurements, Assets that are Measured at Fair Value on a Recurring Basis (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Outstanding (in shares)	7,187,500	7,187,500
Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Outstanding (in shares)	6,100,000	6,100,000
Recurring [Member] | Level 1 [Member]
Assets: [Abstract]
U.S. Money Market Funds	$ 2,917,376	$ 148,742,661
Recurring [Member] | Level 1 [Member] | Public Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	179,688	718,750
Recurring [Member] | Level 1 [Member] | Private Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	0	0
Recurring [Member] | Level 2 [Member]
Assets: [Abstract]
U.S. Money Market Funds	0	0
Recurring [Member] | Level 2 [Member] | Public Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	0	0
Recurring [Member] | Level 2 [Member] | Private Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	152,500	610,000
Recurring [Member] | Level 3 [Member]
Assets: [Abstract]
U.S. Money Market Funds	0	0
Recurring [Member] | Level 3 [Member] | Public Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	0	0
Recurring [Member] | Level 3 [Member] | Private Warrants [Member]
Liabilities: [Abstract]
Warrant Liability	$ 0	$ 0

XML

Fair Value Measurements, Changes in Fair Value of Level 3 Warrant Liabilities (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Warrant [Member] | Public and Private Warrants [Member] | Level 3 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value per share (in dollars per share)	$ 0.025	$ 0.1

XML

Subsequent Events (Details) - USD ($) $ in Millions	Jul. 26, 2023	Jul. 17, 2023	Jan. 24, 2023	Jul. 31, 2023
Subsequent Event [Abstract]
Number of shares held for public (in shares)			1,100,000
Subsequent Event [Member]
Subsequent Event [Abstract]
Proceeds from issuance of common stock to Sponsor		$ 50.0
Number of shares held for public (in shares)	500,000
Subsequent Event [Member] | Sponsor [Member]
Subsequent Event [Abstract]
Proceeds from issuance of common stock to Sponsor		$ 50.0
Shares subject to forfeiture (in shares)				3,631,250
Common stock, shares outstanding (in shares)				1,400,000
Common shares subject to vesting conditions (in shares)				700,000